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 Embryonic stem cell lines (ESCs) can be used for regenerative medicine and drug discov-
ery since they can form any type of cell in the body and self-renew indefinitely. Nowadays, rat ani-
mals appear to be more valuable in the field of biomedicine, than mouse model organisms, in 
terms of their body size, blood system, brain, disease symptoms and others. Thus, rat ESC (rESC) 
self-renewal and pluripotency mechanisms should be investigated rigorously. Although various cell 
signalling pathways responsible for mouse ESC (mESC) maintenance have been studied, very lit-
tle is discovered about rESC. In addition, when ESCs are cultured in the 2i medium, rESCs display 
higher levels of differentiation genes (e.g. GATA4), compared to mESCs. Esteban et al. (2010) re-
ported that Vitamin C improves formation of induced pluripotent stem (iPS) cell colonies. Here, we 
utilised Vitamin C activity to determine if this factor can reduce the spontaneous differentiation of 
rESCs and shift them to a more naïve pluripotent state. Our experimental works consist of three 
main parts, and various research techniques will be employed such as ES cell culture, siRNA 
transfection, morphological analysis, qRT-PCR and flow cytometry. Thus, we will identify if Vitamin 
C can improve rESC self-renewal and restricts differentiation, and subsequently we will determine 
how Vitamin C regulates self-renewal. Our project provides new insight into the mechanisms by 




 Cells derived from embryos can be used for medicine and drug discovery since they can 
form any type of cell in the body (called ‘pluripotency’) and copy themselves indefinitely (called 
‘self-renewal’). Nowadays, rat animals appear to be more valuable in the field of biomedical sci-
ence, than mouse model organisms, in terms of their body size, blood system, brain, disease 
symptoms and others. Thus, the self-renewal and pluripotency mechanisms of rat embryo cells 
should be investigated rigorously. Although various cell signalling pathways responsible for the 
maintenance of mouse embryo cells have been studied, very little is known about rat embryo cells. 
In addition, when incubated in their culture medium, rat embryo cells tend to become different cell 
types, compared to mouse embryo cells. The previously published paper reported that vitamin C 
improves cell conversion from skin cells to embryo cells. Here, we utilised vitamin C activity to see 
if this factor can fully maintain rat embryo cells in a pluripotent state for a longer time. Subsequent-
ly we will determine how vitamin C regulates self-renewal. Our project provides new insight into the 
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 Embryonic stem cells (ESC) represent a valuable research tool since ESCs can form any 
type of cell in the body and self-renew indefinitely (Wray, Kalkan et al. 2010, Kalkan and Smith 
2014). Due to this unlimited developmental and proliferative potential, they have been used exten-
sively in the production of genetic models (Buehr et al., 2008; Meek et al., 2010), and increasingly 
used for regenerative medicine and drug discoveries (Lindvall and Kokaia, 2006; Jensen et al., 
2009; Lindvall and Kokaia, 2010). The convenient size, physiology, behaviours and genetics of rat 
have led this animal into the preferred laboratory model in various fields of biomedical research 
(Jacob and Kwitek, 2002; Aitman et al., 2008; Iannaccone and Jacob, 2009). Since rESCs were 
successfully derived from the blastocyst-stage embryo using MEK and GSK3 inhibitors designated 
as 2i (Buehr et al., 2008; Li et al., 2008), rESCs have been employed as a unique alternative to 
mESC to understand pluripotency and differentiation more rigorously (Meek et al., 2013; Chen et 
al., 2013).  
 Efficient transgenesis requires improved stabilisation of rESC pluripotency (Meek et al., 
2013). Indeed, the long-term culture of rESC in the 2i medium is less reliable than mESC, showing 
higher levels of differentiation genes (e.g. GATA4) (Buehr, Meek et al. 2008, Chen, Blair et al. 
2013, Meek, Wei et al. 2013). Spontaneous differentiation of rESCs in the 2i cultures compromises 
their utility. We propose that changing the epigenetic profile of rESC might strengthen self-renewal 
of undifferentiated cells. At this point, we hypothesise that rESCs exist in a pluripotent state offset 
from the more stable “ground state” typical of mESC (Figure 2.1). The epigenetic modulator ascor-
bic acid or Vitamin C improves somatic cell reprogramming to pluripotency (Esteban and Pei, 
2012). Thus, we are examining whether Vitamin C can stabilise rESCs in the “ground state”. 
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Figure 2.1. Scheme describing the hypothesis that Vitamin C shifts the state of rESCs toward a more 
naïve state.
 
2.2. Embryonic stem cells 
 Embryonic stem cells (ESC) are derived from inner cell mass of blastocyst-stage embryos 
(Figure 2.2) (Evans and Kaufman 1981). ESC displays two unique properties: self-renewal and 
pluripotency. Self-renewal involves generating at least one daughter cell which is identical to the 
mother cell after cell division, retaining the same differentiation capacity, and pluripotency de-
scribes the ability of ESC to form any type of cell in organisms (Wray, Kalkan et al. 2010, Kalkan 
and Smith 2014). Various intrinsic and extrinsic factors depending on the organism regulate ESC 
self-renewal and pluripotency (Smith, 2001; Lanza and Atala, 2014). 
 In 1981, mESCs were first isolated from mouse embryos and grown in culture (Evans and 
Kaufman, 1981; Martin, 1981). Following this discovery, mESC has been extensively investigated 
in biomedical research. Consequently, there are many culture techniques and applications of ESC 
with a remarkable potential (Solter, 2006). Theoretically, ESC research can cure most debilitating 
diseases, for instance, Parkinson’s or Alzheimer’s (Lindvall and Kokaia, 2006; Lindvall and Kokaia, 
2010) and cancer (Dreesen and Brivanlou, 2007; Lanza and Atala, 2014). In addition, ESC can be 
employed to determine signalling pathways responsible for self-renewal and pluripotency, and to 
find out novel drugs (Jensen et al., 2009).  
   
2.2.1. Extracellular signals responsible for self-renewal of ESC 
A. Leukemia inhibitory factor (LIF) 
 An exogenous cytokine, LIF is necessary to maintain the mESC pluripotency. LIF belongs 
to the interleukine-6 (IL-6) family (Gearing et al., 1987; Hirano et al., 1997; Hirai et al., 2011; Eulen-
feld et al., 2012; Tang and Tian, 2013). The IL-6 family receptors make a complex with the receptor 
glycoprotein 130 (Gp130). The LIF receptor is composed of LIF receptor β and a Gp130 het-
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Figure 2.2. ESC derivation and potential. 
ESCs are established from the inner cell mass 
of the blastocyst. ESCs self-renew and differen-
tiate into various cell types (Figure taken from 
Meregalli et al. (2011)).
Self-renewal
 
erodimer (Niwa et al. 2009; Lanner and Rossant, 2010). Upon the LIF addition, three intracellular 
pathways are primarily activated: Grb2-mitogen-activated protein kinase (MAPK), Jak-Stat3 and 
PI3K (phosphatidylinositol-3-OH kinase)-Akt intracellular pathways (Figure 2.3) (Niwa et al., 2009). 
MAPK signalling pathway facilitates mESC differentiation, whereas Jak-Stat3 and PI3K-Akt sig-
nalling pathways promotes mESC self-renewal (Ohtsuka et al., 2015). 
 In terms of Jak-Stat3 pathway, artificial Stat3 activation can substitute the LIF requirement 
for self-renewal of mESC, highlighting that Stat3 acts as an important mediator of the LIF signal 
(Matsuda et al., 1999). Stat3 can maintain mESC self-renewal as demonstrated by Stat3 overex-
pression in serum culture conditions (Niwa et al., 1998; Matsuda et al., 1999; Raz et al., 1999). In 
addition, artificial Akt activation can also replace the LIF requirement. These signalling pathways 
deliver the LIF action into the nuclei in parallel, which upregulates the transcription factors involved 
in maintaining pluripotency (Niwa et al. 2009; Lanner and Rossant, 2010). However, LIF also acti-
vates the MAPK pathway, which is a negative controller of pluripotency. Some groups reported that 
LIF alone cannot support mESC pluripotency and initiates neural differentiation in culture condi-
tions devoid of serum (Wilson and Edlund, 2001; Ying and Smith, 2003; Ying et al., 2003b). In the 
three pathways, the Grb2-MAPK and PI3K-akt pathways are controlled by not only LIF but also 
other extracellular factors e.g. Fibroblast growth factor (Fgf) 4 and insulin/insulin-like growth factor 
(Niwa et al. 2009; Lanner and Rossant, 2010). 
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LIF activates three intracellular pathways: Grb2-
MAPK, Jak-Stat3 and PI3K-Akt intracellular 
pathways. Jak-Stat3 signalling upregulates Klf4, 
while PI3K-Akt signalling facilitates Tbx3 tran-
scription. In addition, MAPK signalling inhibits 
nuclear localisation of Tbx3. The two stimulated 
factors, Klf4 and Tbx3 primarily upregulate 
pluripotency factors, Sox2 and Nanog, respec-
tively. Subsequently, this signal promotes Oct3/4 
expression. Furthermore, Oct3/4, Sox2 and 
Nanog stimulate transcription of all these tran-
scription factors in order to give robustness and 
stable activation when all signals are absent. In 
addition, the Fgf4 pathway is coupling to LIF sig-
nal (Niwa et al., 2009; Lanner and Rossant, 
2010) (Diagram taken from Niwa et al. (2009) 
with the addition of Fgf4 signalling described 
from Lanner and Rossant, (2010)).
Fgf4
Fgfr2
Figure 2.3. Diagram of LIF signal.
 
B. Bone morphogenetic protein 4 (BMP4) 
 A BMP4 is part of the transforming growth factor beta (TGFβ) superfamily. BMP4 is respon-
sible for mesoderm and bone formation in mammals (Xu et al., 2002; Ying et al., 2003a). In 2002, 
BMP4 was initially reported to induce human ESC differentiation to trophoblast (Xu et al., 2002). 
However, Ying et al. (2003a) demonstrated that BMP4 supports the pluripotency of mESC by coor-
dinating with LIF in culture conditions devoid of serum. BMPs function via hetero-dimers of type I 
and type II  serine/threonine kinase receptors (Shi and Massague, 2003). BMP4 and BMP-relative 
growth and differentiation factor-6 (GDF-6) transcripts are prominent in undifferentiated ESCs. The 
downstream targets of BMP receptors are Smad transcription factors (von Bubnoff and Cho, 2001; 
Attisano and Wrana, 2002; Ying et al., 2003a). Active BMP receptor complex recruits R-Smads 1, 
5, and 8 and phosphorylates them. These R-Smads subsequently combine with Smad 4 and enter 
the nucleus to activate inhibitors of differentiation (Id) family (Ying et al., 2003a). Id genes are 
known as principal targets of BMP/Smad signalling in undifferentiated ESCs. Ids are considered as 
negative helix-loop-helix (HLH) factors that restrict E proteins (Class I HLH proteins) for partnering 
with proneural bHLH transcription factors e.g. myoD, mash1, Pax and Ets, and consequently pre-
vent ESC differentiation (Jen et al., 1992; Lyden et al., 1999; Norton, 2000, Ying et al., 2003a) 
(Figure 2.4).  
C. Wnt 
 Wnt is an autocrine stimulus for stabilising naïve pluripotency. Wnt signalling pathway is 
involved in maintenance of self-renewal and pluripotency acting through β catenin (Staal and Sen, 
2008; Meek et al., 2013). β catenin is responsible for gene transcription as well as cell-cell adhe-
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Figure 2.4. BMP/id and LIF/STAT3 signalling cooperatively restrict lineage commitment. 
ESCs should suppress lineage commitment for the maintenance of self-renewal. BMP signals induce Id 
genes to prevent ESC from entering neural lineage differentiation, which is otherwise marginally blocked by 
LIF/STAT3 signalling. Concurrently, STAT3 inhibits the ability of BMP to initiate mesodermal and endoder-
mal lineage commitment. Hence, BMP signal can be turned into the signal that induces lineage differentia-
tion in the absence of LIF (Ying et al., 2003a) (Image adapted from Ying et al. (2003a)).
 
sion (Ben-Ze’ev, 1999). Huelsken et al. (2001) reported that β catenin regulates hair follicle mor-
phogenesis and differentiation of stem cell in the skin.  
 When a Wnt signal is absent (Figure 2.5), β catenin is bound to a complex of Axin, adeno-
matous polyposis coli (APC) protein, GSK3 and casein kinase 1 (CK1) (van Amerongen and 
Nusse, 2009). Sequentially, GSK3 and CK1 phosphorylate β catenin on many serine and threonine 
sites (Staal and Sen, 2008; Lodish et al., 2012). Now a ubiquitin-ligase protein (TrCP) can bind to 
these phosphorylated residues. Subsequently, β catenin is ubiquitinated and destroyed by the 26S 




































Figure 2.5. Wnt signalling pathway. The (A) diagram displays signalling pathway when Wnt is ab-
sent. β catenin is phosphorylated by GSK3 and CK1, and subsequently recognised by TrCP, which leads to 
proteasomal degradation. In contrast, the (B) figure exhibits signalling pathway when Wnt is present. Freed 
β catenin hampers the inhibitory effects of TCF3 on pluripotency markers (e.g. Nanog, Klf2, Tbx3 and Esr-
rb) to maintain pluripotency in ESCs (Lodish et al., 2012; Kalkan and Smith, 2014) (Created using informa-
tion from various sources such as Lodish et al., 2012; Kalkan and Smith, 2014).
 
catenin) associates with the Nanog gene promoter, hindering its gene transcription (Pereira et al., 
2006).  
 In the presence of the Wnt signal, Wnt binds to Frizzled and LRP co-receptor, and phos-
phorylates the LRP cytosolic tail with GSK3 or CK1 (van Amerongen and Nusse, 2009; Lodish et 
al., 2012). This tail binds to Axin, and Dishevelled disrupts the complex of Axin, APC, GSK3, CK1 
and β catenin. This prevents β catenin from phosphorylation by GSK3 and CK1 and ubiquitination 
by TrCP ubiquitin ligase (Lodish et al., 2012). Subsequently, freed β catenin enters the nucleus and 
restricts the inhibitory effects of Tcf3 on pluripotency genes such as Nanog, Klf2, Tbx3 and Esrrb to 
stabilise naïve pluripotency (Pereira et al., 2006; Cole et al., 2008; Zhang et al., 2008; Sokol, 2011; 
Wray et al., 2011; Yi et al., 2011; Kalkan and Smith, 2014). Simultaneously, nuclear-localised β 
catenin associates with Tcf1 to upregulate its transcriptional activity (Yi, Pereira et al. 2011, Chen, 
Blair et al. 2013, Meek, Wei et al. 2013).  
D. Fibroblast growth factor 4 (Fgf4) 
 A Fgf4 is an autocrine molecule for neural differentiation in ESCs (Lowell et al., 2006; Ku-
nath et al., 2007; Revest et al., 2010). Kunath et al. (2007) demonstrated that first, Erk1/2 action in 
ESCs depends on FGF signal. Second, Fgf4-null and wild-type ESCs need FGFR signals for multi-
lineage induction. Last, Fgf4-null and Erk2-null ESCs are deficient in neural commitment. Most of 
the Fgf4-null ESCs remain viable retaining Oct4 expression in the absence of LIF (Kunath et al., 
2007). Fgf4 is expressed between the 8-cell and 16-cell morula in early embryos, but becomes re-
stricted to the epiblast of blastocyst-stage embryos, and are under the regulation of Oct4 and Sox2 
(Yuan et al., 1995). Fibroblast growth factor receptor 2 (Fgfr2) is predominantly expressed in the 
trophectoderm and primitive endoderm in the late blastocyst (Lanner and Rossant, 2010). Elimina-
tion of Fgf4 signals support self-renewal and reduces spontaneous differentiation in the serum me-
dia containing LIF (Lanner and Rossant, 2010). Fgf4-Fgfr2 acts through the Grb2-MAPK pathway 
to restrict pluripotency (Revest et al., 2010). MAKP inhibits nuclear localisation of Tbx3 (Niwa et al., 
2009) (Figure 2.3). Conversely, the pluripotency genes (e.g. Oct3/4 and Sox2) can regulate Fgf4 
expression (Lanner and Rossant, 2010).  
2.2.2. Transcriptional regulation 
2.2.2.1 ESC markers 
A. Oct3/4 
 Oct4 is vital in inducing and maintaining self-renewal in embryo development (Niwa, 
Miyazaki et al. 2000, Niwa, Toyooka et al. 2005). For example, Oct4-null embryos cannot survive 
after implantation. Furthermore, since Oct4 transcriptionally represses trophectoderm-inducing 
genes (e.g. Cdx2), ESCs lacking Oct4 differentiate toward trophectoderm (Niwa, Toyooka et al. 
2005). Interestingly, Oct4 overexpression drives ESCs into a mixture of differentiated cells, other 
than trophectoderm. This is because Oct4 retains its repressor function that prevents trophecto-




 Sox2 produces a heterodimer with Oct4, and controls various ESC genes using a positive 
feedback mechanism (Lanza and Atala, 2014). Sox2 regulates the expression of Oct-Sox en-
hancers as well as nuclear receptor family transcription factors which positively or negatively con-
trol Oct4 expression (Masui et al., 2007). In addition, Niwa et al. (2009) demonstrated that the LIF-
Jak-Stat3 pathway upregulates Klf4, which subsequently activates Sox2 for Oct4 regulation (Figure 
2.6). 
C. Nanog 
 Nanog mRNA appears to be abundant in ESCs, embryonic germ cells, and embryonal car-
cinoma cells, but not in fibroblast, parietal endoderm and hematopoietic cells, indicating that Nanog 
is only expressed in pluripotent cells (Chambers et al., 2003). mESCs fluctuate between high 
Nanog expression state that shows high efficiency of self-renewal and low Nanog expression state 
that exhibits increased differentiation tendency, whereas expression of Oct4 and Sox2 appears to 
be uniform (Chambers et al., 2007; Navarro et al., 2012). Transient Nanog downregulation makes 
ESCs susceptible to differentiation but does not commit. Nanog null ESCs can self-renew indefi-
nitely, even though these cells are prone to differentiate (Chambers et al., 2007). 
 In terms of Nanog regulation (Figure 2.6), Navarro et al. (2012) demonstrated that activity 
of Nanog in mESCs is auto-repressive and Oct4/Sox2-independent. Furthermore, Nanog effects 
on expression of Oct4 and Sox2 is marginal. They also argued that auto-repression would be a 
principal regulator of Nanog transcription switching, highlighting cellular variability in self-renewal 
 13
Figure 2.6. Pluripotency transcription factor network with LIF/Stat3 and GSK3/Tcf3 sig-
nalling. Pluripotency-associated transcription factors are considered to upregulate transcription each oth-
er. Arrows show how each factor controls another (Martello et al. 2012; Navarro et al. 2012; Martello et al., 
2013; Takashima et al., 2014) (Created using information form various sources such as Martello et al. 











Ground State Transcription Factor Circuitry 
 
efficiency of the mESC pluripotency network. Nanog interacts with many transcription factors such 
as Oct4, Esrrb, Sall4, Nr0b1 and Tcfcp2l1 as well as Sox2-interacting factors, Chd7 and the Ncor1 
complex (Gagliardi et al., 2013). Among them, Esrrb acts as a direct target of Nanog as its expres-
sion performs the function of Nanog in ESCs (Festuccia et al., 2012). In addition, elevated Nanog 
in mESCs makes Gp13/LIFR signalling dispensable. Nanog overexpression allows self-renewal 
even after LIF withdrawal, whereas forced maintenance of Oct4 or Sox2 cannot substitute for the 
LIF requirement in self-renewal (Chambers et al., 2003; Lanza and Atala, 2014). Moreover, Nanog 
overexpression with LIF signalling produces maximal self-renewal. This combination condition 
eliminates peripheral differentiation and renders ESC colonies highly compacted (Chambers et al., 
2003). 
2.2.2.2 Early differentiation markers 
A. GATA4 
 GATA4 is a zinc-finger-possessing transcription factor which recognises the consensus se-
quence WGATAR (known as the GATA motif) in the promoters of many target genes (Miyamoto et 
al., 2008). GATA4 is a primitive endoderm marker (Morrisey, Tang et al. 1998, Fujikura, Yamato et 
al. 2002, Holtzinger, Rosenfeld et al. 2010). GATA4 protein regulates genes responsible for em-
bryogenesis and myocardial differentiation (Holtzinger, Rosenfeld et al. 2010), and is essential for 
testicular development (NCBI, 2016). In mice, GATA4 is highly upregulated in the somatic cells of 
the developing gonad around the time of sex determination (Viger et al., 1998). GATA4 mutations 
may produce cardiac septal defects. Furthermore, aberrant gene expression may generate multiple 
types of tumours (NCBI, 2016). 
B. Brachyury 
 Brachyury is a key transcription factor that develops mesoderm during gastrulation, and 
directly upregulated by β catenin. In naïve mESC, Brachyury expression levels are very low, but 
their levels are elevated in primed-type EpiSCs, representing a differentiation marker of early-stage 
mESC (Bernemann et al., 2011; Kelly et al., 2011). 
C. Cdx2 
 Cdx2 was regarded as a trophoblast marker (Niwa, Toyooka et al. 2005), however Bernar-
do et al. (2011) cited that BMP causes pluripotent stem cells mainly to form mesoderm through 
Brachyury and Cdx2 transcription factors, highlighting association of Cdx2 with mesoderm forma-




2.3. Rat as a model organism 
2.3.1. Rat is a better animal model than mouse? 
 Rats provide various advantages over mice as a human disease model. Rat ESC derivation 
will significantly expand their utility in medical research (Buehr et al., 2008). Rat is considered as 
an excellent model in various aspects for many diseases including cardiovascular disease (e.g. 
hypertension and stroke). Rat is physiologically and pharmacologically closer to human (Jacob and 
Kwitek, 2002; Aitman et al., 2008; Iannaccone and Jacob, 2009).  
 The animal size increases its use as a model of disease. The body size of rat is bigger, thus 
all the organs and cancers are bigger. This means that laboratory researchers can easily monitor 
their physiology for their studies including the central nervous system. In the studies of breast can-
cer, rat exhibits similar hormone response and premalignant stages which resemble the human 
disease (Iannaccone and Jacob, 2009). The vascular system and brain of rat are more relevant to 
those of humans than mouse. A rat heart beats approximately four times faster than a human 
heart, whereas a mouse heart beats almost six times faster. Rats with divergent blood pressures 
are used as a model organism for genetic dissection of the inherited hypertension causes (Rapp, 
2000). In addition, a larger brain of rat is more complex than a mouse brain. Hence, neurological 
diseases such as Parkinson’s and Alzheimer’s can be investigated more rigorously using rat mod-
els. Furthermore, rats are superior to other animal models in cognition and memory research, since 
they are more intelligent, and can learn a lot of different tasks compared to mice. Also, rats are bet-
ter to monitor for the research of diabetes, since they behave more similar to the human disease, 
including the response to environmental factors such as stress, diet and toxins. Likewise, rats ap-
pear to metabolise medicine in an analogous manner our body breaks and absorbs a substance, 
because of similar liver enzymes mice do not possess (Jacob and Kwitek, 2002; Li et al, 2008; 
Aitman et al, 2008; Iannaccone and Jacob, 2009; Phillips et al., 2013). 
 Although rats have various advantages over mice, they also have some disadvantages. 
First, rats are not easier to keep them in a laboratory and cost more than mice. The larger body 
size of rats requires more food and space. Second, scientists who studied a mouse model for a 
long time tend to keep working with the same model, since mice still offer other advantages (Li et 
al, 2008; Iannaccone and Jacob, 2009; Phillips et al., 2013). 
2.3.2. Mouse ESC vs Rat ESC 
 Rats and mice look very similar, but they evolutionally separated over 12 million years ago 
(Gibbs et al., 2004). Thus, a rat should not be considered as just a big version of a mouse. When a 
certain signalling pattern is observed in mice, it does not indicates that it must be there in rats. If 
some patterns are observed in both rats and mice, then the chances would be much higher that it 
generalises to other animals, including human (Phillips et al., 2013; Till et al., 2015). Due to the 
large evolutionary distance, rESC maintenance is different from mESC and more challenging 
(Buehr et al., 2008). Since we have less information for their maintenance, we should further study 
rESC to extensively utilise rats as a disease model. 
 Although both mESC and rESC express the identical pluripotency transcription factors (e.g. 
Nanog, Oct4, Sox2 and Klf), there are several differences between them. First, in terms of mice, 
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LIF alone sustains mESC self-renewal, primarily acting through the Stat3-Tfcp2l1/Klf4 pathway 
(Martello et al., 2013). The addition of both LIF and BMP4 maintains mESC self-renewal in serum-
free N2B27 media, although its physiological action are restricted during development (Ying et al., 
2003a). Second, regarding rats, two inhibitor system, 2i (inhibitors of MEK and GSK3) or three in-
hibitor system, 3i (inhibitors of MEK, GSK3 and FGF receptor) can maintain rESCs in the presence 
of LIF. But, LIF alone does not retain rESC self-renewal (Buehr et al., 2008). Interestingly, serum 
induces rESC differentiation, and BMP4 has no positive influences (Li et al., 2008). Additionally, 
compared with the mouse cells, rat ESCs do not grow very well on feeder-free plates. One of the 
significant differences found between rats and mice is β catenin activity levels (Meek et al., 2013). 
β catenin regulates rESC self-renewal in a concentration-dependent way, which have not observed 
in mESC. rESC contains higher β catenin activity levels compared to mESC, since high β catenin 
levels caused by the high GSK3 inhibitor concentration (e.g. over 6µM CHIR) can induce differenti-
ation in rESC but maintain self-renewal in mESC. This highlights that GSK3β inhibition is not nec-
essarily required in rESC. Therefore, rESC self-renewal can be promoted by MEK inhibitor (1i) 
alone (Meek et al., 2013). Although both rat and mouse ESCs show similar signalling systems and 
gene expressions, they exhibit some dissimilarity regarding ESC maintenance (Figure 2.7), due to 
the big evolutionary distance (Gibbs et al., 2004). To efficiently derive true naÏve rESCs for their 
broader applications, we should further investigate rESCs. 
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• Only 2i or 3i systems can support self-renewal 
• LIF alone can maintain self-renewal 
• BMP4 with LIF promotes self-renewal in serum-free media 
• Most ESCs grow well on feeder-free plates 
• Relatively low β catenin activity
• LIF + 1i, 2i or 3i systems can support self-renewal  
• LIF alone cannot maintain self-renewal 
• BMP4 has no influence 
• Most ESCs do not survive on feeder-free plates 
• Relatively high β catenin activity
Mouse ES cellsRat ES cells
Figure 2.7. Summary of the different features of ESC maintenance between rat ESCs and 
mouse ESCs. Left red box exhibits the characteristics of rat ESC maintenance. Right blue box displays 
the characteristics of mouse ESC maintenance (Buehr et al., 2008; Li et al., 2008; Ying et al., 2003a; 
Martello et al., 2013; Meek et al., 2013).
 
2.4. Vitamin C 
 Vitamin C (L-ascorbic acid) is known as an essential nutrient for primates including hu-
mans. Although most mammals produce ascorbate via a metabolic pathway from glucose, some 
animals (e.g. primates, guinea pigs and bats) have lost the last enzyme (Vitamin C-regulated gu-
lonolactone oxidase) in the pathway, because of mutation accumulation (Drouin et al., 2011; Mon-
fort and Wutz, 2013). Thus, we have to take Vitamin C-containing food such as fruits and vegeta-
bles.  
 
 Vitamin C deficiency results in loss of collagen hydroxylase activity, which causes a struc-
tural breakdown of the epithelia and skin, called scurvy (Peterkofsky, 1991; Baron, 2009). In addi-
tion, Vitamin C controls hypoxia response by regulating HIF prolyl-hydroxylases. Vitamin C is an 
electron donor for changing the redox state of iron-possesing enzymes. That is, it reduces iron 
atom where it is oxidised to dehydro L-ascorbic acid (Figure 2.8). However, other antioxidants are 
also effective for this reaction, and can substitute for Vitamin C. In mice lacking Vitamin C, glu-
tathione can replace with Vitamin C in retaining the prolyl-hydroxylase activity in the pathway of 
hypoxia response (Nytko et al., 2011). 
 In the presence of iron in the Fe(IV) state, Vitamin C produces two electrons to switch the 
iron to the Fe(II) state, which activates 𝛂-ketoglutarate (2OG)-dependent dioxygenases (Figure 
2.9). These dioxygenases oxidatively decompose 2OG to succinate and CO2, thereby producing 
an Fe(IV)-oxo intermediate. Subsequently, the activated oxygen species hydroxylate a substrate 
(e.g. DNA or histone), which restores the Fe(II) and removes methylation. When substrate is ab-
sent, the iron remains in a higher oxidation state that blocks further catalysis (Monfort and Wutz, 




Figure 2.8. Vitamin C structure and function. (A) L-ascorbic acid indicates Vitamin C, while its opti-
cal isomer, D-ascorbic acid does not give the equivalent biological effect. But antioxidant effects are same 
in the L- and D-forms. (B) When Vitamin C is oxidised to DHA, it produces two electrons which act as a 





2.5. Vitamin C-mediated dioxygenases regulate epigenetics. 
 Fe(II) 2OG-dependent dioxygenases require Vitamin C to retain their catalytic activity, be-
cause they are very susceptible to environmental factors such as onco-metabolites (Dang et al., 
2009; Ward et al., 2010; Yang et al., 2012). These dioxygenases show hydroxylase activity acting 
through their JmjC domain. This domain frequently associates with other domains which give se-
lective binding, on the basis of the histone or DNA methylation status (Upadhyay et al., 2011). The 
catalytic JmjC domain of dioxygenases is arranged in a double-stranded β-helix fold, which is 
composed of eight β-strands and possesses one catalytic iron-coordinating aspartate (or gluta-
mate) and a triad of two histidines (Clifton et al., 2006). JmjC-domain-containing histone demethy-
lases oxidatively removes methylation of lysine residues of histones using iron Fe(II) and 2OG 
(Tsukada et al., 2006; Yamane et al., 2006; He et al., 2008; Horton et al., 2010; Hsia et al., 2010; 
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Figure 2.9. Dioxygenase catalysis. Dioxygenase catalysis acts through the substrate hydroxylation 
cycle or the Vitamin C-dependent regeneration cycle. Vitamin C reduces iron to Fe(II) in dioxygenases (e.g. 
DNA- and histone-modifying enzymes). Oxygen decarboxylates 2OG in the dioxygenases, forming an acti-
vated Fe(IV) enzyme. When substrate is present, the activated enzyme combines with substrate and re-
leases succinate. Subsequently the dioxygenase hydroxylates the methyl part of the substrate, and Fe(IV) 
is concurrently reduced to Fe(II). When substrate is absent, the activated enzyme releases succinate with-
out Fe(IV) reduction to become inactive (Monfort and Wutz, 2013) (Image taken from Monfort and Wutz, 
(2013)).
 
Kim et al., 2010; Qi et al., 2010; Sinha et al., 2010; Wen et al., 2010; Yu et al., 2010; Kim et al., 
2012). While the flavin cofactor-dependent histone demethylases only eliminate mono- and di-
methyl-lysine modifications, several JmjC-domain-containing histone demethylases can also re-
move methylation of tri-methylated histone lysines (Cloos et al., 2006; Fodor et al., 2006; Klose et 
al., 2006; Whetstine et al., 2006; Agger et al., 2007; Hong et al., 2007; Iwase et al., 2007; Klose et 
al., 2007; Seward et al., 2007). The cofactor-bound JmjC domain forms a very reactive oxoferryl 
intermediate which hydroxylates the lysine-methyl group in histone. The methyl group removal 
from the histone tail is completed by formaldehyde elimination (Figure 2.10). In addition to lysine 
methylation, there is also arginine methylation. For example, histone tails may be mono- and di-
methylated on arginines. Likewise, this arginine methylation affects chromatin remodelling, thereby 
regulating gene expression involved in cell fate transitions (Torres-Padilla et al., 2007). 
 
2.5.1. Vitamin C downstream targets  
2.5.1.1. DNA hydroxylases - TET methylcytosine dioxygenases 
 The ten-eleven-translocation genes 1-3 (TET1-3) perform 5mC oxidation in DNA. TET en-
zymes oxidise 5mC (5-methyl-cytosine) to produce 5hmC (5-hydroxy-methyl-cytosine). This leads 
to the formation of 5fC (5-formyl-cytosine) and 5caC (5-carboxyl-cytosine). Subsequently, thymine 
DNA glycosylase (TDG) recognises and excises 5caC (Tahiliani et al., 2009; Ito et al., 2010; He et 
al., 2011; Ito et al., 2011; Wu and Zhang et al., 2011; Huang and Rao, 2014) (Figure 2.11). TET en-
zymes contain a DSBH fold in their catalytic domain that associates with Fe(II) and 2OG. Further-
more, intriguingly, only TET1 and TET3 possess a zinc finger domain which may stimulate interac-
tion with DNA. In ESCs, transcription start segments of gene promoters and exons exhibit abun-
dant 5hmC. Thus, TET proteins are considered to regulate target genes of Polycomb group pro-
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Figure 2.10. The methyl group removal from lysines of histones by histone demethylases. 
JmjC-domain containing histone demethylases remove methyl parts from lysines of histones. After the for-
mation of the unstable oxoferryl intermediate (i.e. the Fe(II) enzyme containing the substrate-CH2-OH), this 
oxidised methyl parts are spontaneously released as formaldehyde (CH2O) to regenerate unmodified 








teins (Pastor et al., 2011; Xu et al., 2011). In addition, mESCs show Tet1 and Tet2 expressions 
within which Tet3 expressions are scarcely found. In contrast, in fibroblasts, there are little expres-
sion of Tet1, intermediate expression of Tet2 and high expression of Tet3 (Monfort and Wutz, 
2013). Pluripotency transcription factors regulate Tet gene expression. For example, Oct4 knock-
down downregulates Tet1 and upregulates Tet3, reducing the 5hmC levels (Koh et al., 2011). This 
indicates that Tet1 may play an important role in mESCs.  
 Some cancers can be developed by mutations in TET1 and TET2 with a concomitant re-
duction in the 5hmC levels. For instance, TET1 functions as an MLL partner in myeloid and lym-
phoid leukaemia. Tet2 mutations are implicated in myeloid leukaemias (Delhommeau et al., 2009). 
During mouse germline development, Tet1 affects DNA demethylation involved in genome-wide 
reprogramming (Hackett et al., 2012). Tet3 regulates 5mC hydroxylation on the sperm chromo-
somes in zygotes (Gu et al., 2011), while Stella binding protects the maternal chromosomes of the 
oocyte from Tet3 activity (Nakamura et al., 2012). This generates a differential modification of pa-
ternal chromosomes with 5hmC and maternal chromosomes with 5mC in preimplantation embryos 
(Monfort and Wutz, 2013).  
2.5.1.2. Histone demethylases 
 Histone demethylase activities are frequently investigated through the iPS cell research. 
During reprogramming, Vitamin C reduces histone H3 Lys36 di-methylation (H3K36me2) and tri-
methylation using the histone demethylases, Kdm2a and Kdm2b (or Jhdm1a and Jhdm1b) (Wang 
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Figure 2.11. Tet-mediated DNA demethylation. DNA methyltransferases (Dnmt) establish 5mC. Tet 
dioxygenases hydroxylate 5mC to form sequentially 5hmC, 5fC and 5caC. DNA glycosylase (e.g. TDG)-
mediated base excision repair (BER) excises 5fC and 5caC from DNA. In addition, a putative decarboxy-
lase might directly change 5caC to cytosine (Wu and Zhang et al., 2011; Huang and Rao, 2014) (Created 














et al., 2011), and increases H3 Lys27 tri-methylation at the INK4/ARF locus to repress this gene 
(He et al., 2008; Li et al., 2009; Tzatsos et al., 2009). The INK4/ARF locus (or CDKN2A gene), 
which is a barrier for iPSC reprogramming (Li et al., 2009), produces tumour suppressors called 
p16INK4a and p14ARF in humans (or p19ARF in mice) proteins. The former INK4a protein binds to 
CDK4 and CDK6 proteins to block them from stimulating cell cycle progression. The latter ARF 
protein protects the p53 protein from being degraded in order to block tumour formation (Kim and 
Sharpless, 2006; Calvo et al., 2016). Normal somatic cells basally express INK4/ARF, whereas 
ESCs and iPSCs completely silence them (Li et al., 2009). In addition, ageing is related to in-
creased INK4/ARF expression (Agherbi et al., 2009). Taken together, reprogramming of somatic 
cells is proliferation-dependent, and the expression of the INK4/ARF locus limits the reprogram-
ming efficiency (Li et al., 2009) (Figure 2.12).  
 During reprogramming with Oct4 and KDM2B (JHDM1B) expression, Vitamin C upregu-
lates the microRNA (miR or miRNA) 302/367 gene (a target of Oct4 and Sox2 in ESCs) (Wang et 
al., 2011; Card et al., 2008; Marson et al., 2008). The miRNAs are small non-coding RNAs that 
regulate gene expression post-transcriptionally. The miR-302/367 cluster consists of miR-302a, 
miR302b, miR-302c, miR-302d and miR-367. This intragenic cluster is located in the LARP7 (La-
related protein 7) gene (Gao et al., 2015). KDM2B reduces histone H3 Lys36 methylation levels 
around the Oct4 binding sites of the miR302/367 cluster and promotes gene expression (Wang et 
al., 2011). The miR302/367 gene positively controls pluripotency by inhibiting genes necessary for 
embryonic differentiation (Houbaviy et al., 2003). Upon differentiation, expression of miR302/367 
gene quickly disappears (Suh et al., 2004). Anokye-Danso et al. (2011) reported that the 
miR302/367 cluster expression alone can induce reprogramming of human fibroblasts to pluripo-
tency. This miR302/367-mediated reprogramming requires inhibition of histone deacetylase 2 and 
miR367 (an essential Oct4 activator). Overall, the Vitamin C potential targets, Kdm2a and Kdm2b 
might activate miR302/367 during iPSC generation (Esteban and Pei, 2012) (Figure 2.12). 
 In addition, Vitamin C can convert pre-iPSCs to fully-reprogrammed iPSCs (Esteban et al., 
2010). According to the paper of Chen et al. (2012), H3K9 methylations on ESC genes repress 
pluripotency. Moreover, Vitamin C decreases H3K9 di-methylation, activating gene expression. In 
this system, Vitamin C synergises with suppression of the Lys9-targeted methyltransferases (e.g. 
Setdb1, G9a, Suv39h1 and Suv39h2), significantly enhancing the reprogramming efficiency. 
Hence, suppression of Setdb1 can also shift pre-iPSCs to the ground state of pluripotency in the 
absence of Vitamin C (Chen et al., 2012). In addition to the H3K36 demethylases (Kdm2a and 
Kdm2b), Vitamin C also upregulates the H3K9 demethylases, such as Kdm3a, Kdm3b, Kdm4b and 
Kdm4c in the reprogramming process; this indicates that histone H3K9 demethylation is critical for 
conversion of pre-iPSCs to iPSCs (Monfort and Wutz, 2013). Furthermore, Mansour et al. (2012) 
argued that somatic cell reprogramming is also regulated by the H3K27 demethylase, Kdm6a 
(Utx). In summary, Vitamin C-targeted Fe(II) 2OG-dependent histone demethylases play a signifi-




Figure 2.12. Potential Vitamin C-mediated reprogramming mechanism. Vitamin C activates 
histone demethylases, which increase reprogramming efficiency. Kdm2a and Kdm2b upregulate the 
miR302/367 cluster and inhibit the Cdkn2a locus that encodes Ink4a and Arf. The activated miR302/367 
cluster induces mesenchymal-to-epithelial transition (MET). The repressed Ink4a and Arf promote p53 
degradation, thereby preventing senescence and apoptosis. In addition, Vitamin C increases activity of Tet 
hydroxylases, which maintain the Dlk1-Dio3 locus imprinting. This activity consequently improves repro-
gramming fidelity (Kawamura et al., 2009; Anokye-Danso et al., 2011; Esteban and Pei, 2012) (Created 
using information form different sources such as Kawamura et al., 2009; Anokye-Danso et al., 2011; Este-



















2.6. Vitamin C effects on inducing pluripotency. 
 Vitamin C-dependent enzyme activity is important during reprogramming. Somatic cells 
rapidly undergo senescence under culture media, partly due to accumulation of reactive oxygen 
species (ROS) generated by cellular metabolism (Parrinello et al., 2003). In addition to somatic 
cells, ROS also increases in the three factors (Sox2/Klf4/Oct4)-transduced reprogramming of 
mouse fibroblasts, but this is less efficient than the four factors (Sox2/Klf4/Oct4/c-Myc)-induced 
reprogramming, which has a lower ROS generation (Esteban et al., 2010). This suggests that an-
tioxidant activity of Vitamin C may enhance this process. However, multiple antioxidants (e.g. Vit-
amin B1, Vitamin E, resveratrol, 𝛂-lipoic acid, reduced gluthatione, L-carnitine hydrochloride, 
amino-acetyl-cysteine and sodium selenite) do not noticeably enhance the generation of iPS cells 
(Esteban et al., 2010). This highlights the importance of the Vitamin C-dependent enzyme activity. 
Vitamin C promotes formation of iPSC colonies by decreasing p53 levels and counteracting cell 
senescence, a roadblock for reprogramming (Esteban et al., 2010). Generally, anti-proliferative p53 
and Rb pathways are activated to induce senescence or apoptosis in aberrant cells. Deleting p53 
(or its target p21 gene) enhances reprogramming of somatic cells (Kawamura et al., 2009), pre-
sumably by improving their proliferation. 
 Generally, when transduced with reprogramming factors, the somatic genes are efficiently 
repressed, whereas the pluripotency genes are induced inefficiently (Mikkelsen et al., 2008). Vita-
min C de-methylates DNA on genes which are regulated by bivalent chromatin and genes which 
are de-methylated during reprogramming (Chung et al., 2010). Reprogramming with Vitamin C 
elimination decreases a iPS cell quality, causing hyper-methylation of the imprinted Dlk1-Dio3 lo-
cus (Stadtfeld et al., 2012). Vitamin C can block this aberrant methylation, although it is insufficient 
to remove the hyper-methylation once formed (Carey et al., 2011; Stadtfeld et al., 2012). The pat-
terns of mRNA and miRNA expression are almost identical between ESCs and iPSCs, except tran-
scripts of the Dlk1-Dio3 gene cluster. This gene cluster expression is abnormally reduced in iPSCs, 
which poorly generate chimeras and do not develop entirely iPSC-derived mice, due to the inactivi-
ty of histone H3 acetylation, H3K4me2/me3 and DNA methylation formation on the maternal allele 
(Stadtfeld et al., 2010). Valproic acid (a histone deacetylation inhibitor) can reactivate histone H3 
acetylation and permissive H3K4 methylation on the muted Dlk1-Dio3 locus, thereby increasing the 
reprogramming efficiency (Anokye-Danso et al., 2011; Stadtfeld et al., 2012). In contrast, Vitamin C 
can block the reduction of histone H3 acetylation and H3K4 methylation, maintaining imprinted 
DNA methylation patterns on the Dlk1-Dio3 locus. This maintenance of correct Dlk1-Dio3 imprint-
ing facilitates generation of iPS cells with an enhanced differentiation potential (Stadtfeld et al., 
2010; Stadtfeld et al., 2012). Interestingly, the progeny of mice containing mutations in Tet1 and 
Tet2 carry aberrant Dlk1 imprinting in the locus. Furthermore, Tet1 and Tet2 are reported to im-
prove reprogramming efficiency (Doege et al., 2012; Costa et al., 2013). In addition to the mainte-
nance of Dlk1-Dio3 loci, Vitamin C can also partly overcome the epigenetic roadblocks towards 
ESC pluripotency by upregulating the miR302/367 and downregulating INK4/ARF (Figure 2.12). 
Moreover, Vitamin C extensively affects metabolic functions which might also induce indirect ef-
fects via other signalling pathways (Nelson et al., 1981; Knowles et al., 2003; Chowdhury et al., 
2011; Nytko et al., 2011; Du et al., 2012). 
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 Taken all together, Vitamin C increases enzyme activity of Fe(II) 2OG-dependent dioxyge-
nases. Subsequently, these enzymes reduce histone and DNA methylation levels during somatic 
cell reprogramming to achieve pluripotency. Hence, it is tempting to speculate that Vitamin C can 
change the epigenetic profile of rat ESC and improve rat ESC pluripotency and self-renewal from 
the peri-naive ESC state. 
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2.7. Objectives of the project 
 Maintaining rat ESC in the “ground state” can expand their applications extensively. But, rat 
ESCs are sensitive to differentiation, compared with mouse ESCs. This issue should be solved to 
utilise rESCs for their extensive applications. Esteban et al. (2010) reported that Vitamin C boosts 
formation of mouse and human iPSC colonies. Our aim within this project is to establish assays of 
Vitamin C activity to determine whether Vitamin C improves rESC self-renewal or prevents rESCs 
from differentiation in the lineage-inducing conditions. Subsequently, we will identify how Vitamin C 
can stabilise rESC pluripotency at the molecular level. In this project, we will specifically look at the 
following:  
 - Whether Vitamin C enhances rESC proliferation. 
 - Whether Vitamin C prevents differentiation and supports intrinsic self-renewal. 
 - If it acts positively, what downstream targets are involved in the Vitamin C activity. 
  
 All of these questions would be answered following various experiments outlined below 
(Figure 2.13). Consequently, this project will provide insights into the process how Vitamin C pro-
motes rat ESC pluripotency in the “ground state”.  
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Assays of Vitamin C activity 
• Improving rESC growth 
• Preventing rESC differentiation
Identifying Vitamin C downstream targets 
• Transfection of rESCs 
• siRNA validation of TET and KDM 
• siRNA knockdown of TET and KDM in Vitamin C-treated rESCs
Screening more targets
Figure 2.13. Experimental work 
plan. The step-by-step work in the 
Vitamin C project is described from 
top to bottom. Each box exhibits dif-
ferent works of the project with de-
tailed plans.
 
2.8. Outline of experiments 
2.8.1. Assays of Vitamin C activity 
2.8.1.1. Improving rESC growth. 
  Rat ESCs will be cultured in 2i+LIF under the following conditions: Mock (water), Vitamin C 
and its isomer, D-isoascorbic acid (lacking cofactor activity). These culture conditions would allow 
us to determine whether Vitamin C can enhance rESC proliferation. Additionally, mouse ESC 
growth will be examined to compare with rat ESC proliferation. 
2.8.1.2. Preventing rESC differentiation 
 Rat ESCs will be cultured in the differentiation-inducing condition (i.e. the 2i media contain-
ing high levels of GSK3 inhibitor) in the absence or presence of Vitamin C. This experiment will 
enable us to identify whether Vitamin C can rescue rESCs from differentiation. To determine their 
response to addition of Vitamin C, we will observe ESC morphology, the proportion of pluripotent 
cells and gene expression by using fluorescent microscope, flow cytometry and qRT-PCR expres-
sion profile. 
2.8.2. Identifying downstream targets of Vitamin C 
2.8.2.1. Transfection of rESCs 
 To determine how Vitamin C mediate its activity in ESCs, we will investigate potential 
downstream targets using siRNA knockdown. Before we conduct siRNA knockdown, transfection 
efficiency will be increased as near to 100% of the cells as possible to have the reliable knockdown 
effect of downstream targets. This efficiency will be maximised by modulating concentration of 
CHIR99021 (GSK3β inhibitor), Vitamin C and siRNA. 
2.8.2.2. siRNA validation of TET and KDM 
 After transfecting siRNA into ES cells, siRNA may possibly cleave off-target mRNAs. To de-
termine the effect of knockdown of target mRNAs, we will use qRT-PCR that measures the target 
mRNA levels to validate siRNA activity. 
2.8.2.3. siRNA knockdown of TET and KDM in Vitamin C treated rESCs 
 Transfecting cells with TET & KDM siRNA and control siRNA in the presence or absence of 
Vitamin C will determine role of target in Vitamin C-mediated activity. 
2.8.3. Screening more targets 
 If the siRNA knockdown of TET and KDM does not remove the the Vitamin C-mediated ac-




 Rat ESCs are extensively utilised in the field of biomedicine such as the generation of ge-
netic models. However, this utility depends on reliable maintenance of stable ES cells in a self-re-
newing, pluripotent state. Although rat ESC are successfully derived from rat blastocysts using 
MEK and GSK3 inhibitors, spontaneous differentiation of rat ESCs in the 2i+LIF cultures limit their 
utility. Based on various relevant studies, Vitamin C seems to reduce this differentiation and im-
proves self-renewal of undifferentiated ESCs. Our project will establish assays of Vitamin C activity 
and investigates the downstream epigenetic mechanisms regulating these changes. This will give 
fresh insight into the Vitamin C-mediated ES cell stabilisation. 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3. Materials and Methods
3.1. Reporter of rat embryonic stem cells  
 In the rESC reporter, one of Rex1 alleles was replaced by GFP. Thus, this GFP is posi-
tioned under the control of the Rex1 promoter. Rex1 is found in undifferentiated ESCs, but lost in 
differentiated ESCs (Shi et al. 2006). This allows us to track the ESC state between differentiated 
and undifferentiated cells. Since the undifferentiated cells show a Rex1-GFP expression, we can 
observe green-positive cells under the fluorescence microscope, whereas differentiated cells are 
green-negative.  
3.2. Culture of rat embryonic stem cells  
 ESCs were cultured on a monolayer of 𝞬-irradiated (5 Gy) mouse embryonic fibroblasts 
(MEFs) in 2i + LIF medium in 24-well plates, and incubated at 37℃ and 5% CO2 in humidified air. 
The 2i + LIF medium consists of 1µM PD0325901 (PD, acquired from Axon Medchem), 3µM 
CHIR99021 (CHIR, acquired from Axon Medchem), 1000U/ml mouse LIF and N2B27 in Table 1. 
DMSO was used to dissolve the inhibitor powder to 10mM as a stock solution and stored at -20℃. 
This solution was then diluted to 1mM using N2B27. Regarding feeder cells, the MEFs were treat-
ed with gamma irradiation to inactivate them. 
3.2.1 Passaging Rat Embryonic Stem Cells 
 ESCs were passaged every two or three days. To passage them, medium was first aspirat-
ed and 200µl TYP (0.025% trypsin, 1% chicken serum and 1 mM EDTA) was added into a 2cm2 
well of 24-well plates. These cells were then incubated at room temperature for 2-3 minutes, and 
dispersed to a single cell suspension. They were subsequently resuspended in 4ml N2B27 and 
pelleted by centrifugation at 1000 rpm for 3 minutes. After aspirating the supernatant, the cell pellet 
was resuspended in 0.5 or 1ml 2i+LIF medium. Lastly, the cells were plated at a density of 5 to 7.5 
x 104 / cm2 onto the feeder cells, MEFs. 
3.3. Cell Proliferation Assay 
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Table 1. N2B27 base 
medium and 2i+LIF 
medium. Each component of 
N2B27 and 2i+LIF media is 
shown.
N2B27 base medium 2i+LIF medium
DMEM/F12 medium  250 ml (50%) N2B27 medium
Neurobasal medium  250 ml (50%) PD0325901 (1µM)
N2 supplement  2.5 ml (0.5%) CHIR99021 (3µM)
B27 supplement - no vitamin A  5 ml (1.0%) Mouse LIF (1000U/ml)
L-glutamine (200mM)  5 ml (2mM)
β-mercaptoethanol (50mM)  1 ml (0.1mM)
 
 ESCs were plated in quadruplicate at a density of 500 per well of a 96-well plate. Cell 
growth was assayed utilising the CyQUANT® Direct Cell Proliferation Assay kit (supplied by Ther-
mo Fisher Scientific) at 1, 24, 48, 72, and 96 hours, following the instructions of the manufacturer.  
3.4. Inducing Differentiation of Rat Embryonic Stem Cells 
 In order to determine Vitamin C influence on ESC differentiation, concentrations of CHIR 
and PD were modulated in 2i medium to generate differentiated rESCs. As for CHIR assay, high 
CHIR concentration (≧ 4µM) was applied to increase β catenin activity, which leads to upregulation 
of differentiation genes (e.g. LEF1). As for PD experiments, low concentration of PD (≦ 0.25µM) 
was used to promote positive role of MEK on ESC differentiation. 
3.5. Treatment of D- and L-ascorbic acid media 
 Due to the unstable nature of L-ascorbic acid in water, 2-Phospho-L-ascorbic acid trisodium 
salt (supplied by Sigma Aldrich) was used instead, as a stable derivative in cell culture. In addition, 
fresh stock was made for every experiment. For working stock, 100mg L-ascorbic acid powder was 
dissolved in 10ml RNase-free water. Subsequently, 32.25µl of this solution was added into the ap-
propriate 10ml medium to produce 100µM L-ascorbic acid medium. Likewise, 100mg D-ascorbic 
acid (D-isoascorbic acid) powder (supplied by Sigma Aldrich) was loaded in 10ml water. Then, 
17.5µl of this stock was added into 10ml medium (e.g. 2i+LIF medium) to generate 100µM D-
isoascorbic acid medium. 
3.6. siRNA Knockdown 
 In 24 well plates, ESCs were transfected with the appropriate small interfering RNA (siRNA) 
to knockdown the Vitamin C targets. Potentially, this target siRNA can remove the ESC phenotype 
rescued by Vitamin C in the pro-differentiation condition; this may identify the downstream targets 
of Vitamin C. Before siRNAs were employed in our experiments, we determined the optimal siRNA 
concentration in order to obtain the highest knockdown. Here, Lipofectamine LTX (Invitrogen) was 
used as a transfection reagent, following the manufacturer’s instructions. Firstly, the desired num-
ber of cells were loaded in the 500ul 2i+LIF medium, and then the appropriate amount of siRNA 
was added in the 100ul OptiMEM medium containing 3.5ul LTX and 1ul PLUS reagent. In addition, 
a negative control siRNA (supplied by Ambion, 4390846) was used. After 24 hours, we replaced 
the liposome-transfection mix with a relevant fresh medium. 
3.7. qRT-PCR 
 A maximum of 5 x 106 cells were harvested as a cell pellet. β-mercaptoethanol was added 
into cell pellet samples, since it is a reducing agent which helps to remove tannins and other 
polyphenols. Their RNAs were then isolated employing RNeasy Mini Kit (QIAGEN), and cDNAs 
were synthesised utilising AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Tech-
nologies). The first-strand cDNA in each sample was suspended in 1ml of RNase-free water. After 
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this dilution,10µl of cDNA was added into each well of the 96 well-plate (qRT-PCR plate) in tripli-
cate. Subsequently 15µl of master-mix (12.5µl of SYBR green mix, 1µl of 10uM forward primer, 1µl 
of 10µM reverse primer and 0.5µl of ROX dye) was added into each well, using SYBR Green 
qPCR Kit (Invitrogen) in Table S1. GAPDH was employed as a housekeeping gene, relative to 
which the expression level is defined. This constitutive gene is required to maintain basic cellular 
activity in all animal cells, since it catalyses one of the steps in glycolysis to generate energy. The 
qRT-PCR plate was briefly centrifuged and run on the strategene MX3000P machine following the 
step in Table 2. 
3.8. Luciferase Assay 
 ESCs were transfected with plasmid (360 ng) (SUPERTOP-FLASH or FOP-FLASH) and 
pEF1𝛂-renilla (6.25 ng) (Hay, Sutherland et al. 2004) employing LTX, Lipofectamine and PLUS 
reagents (supplied by Invitrogen) at a density of 5 x 104 / cm2. Cells were lysed after 2 days and 
analysed employing the Dual-Luciferase Reporter System (outlined in Promega, Madison, WI, 
http://www.promega.com). The level of luciferase was normalised to activity of renilla. Results are 
shown as a ratio of activity of SUPERTOP-FLASH to FOP-FLASH. 
  
3.9. Single cell analysis (Flow cytometry) 
 ESCs were trypsinised using 200µl TYP and dispersed to a single cell suspension. Subse-
quently, they were resuspended in 4ml N2B27 and pelleted by centrifugation at 1000 rpm for 3 
minutes. The cell pellet was then resuspended in 200-500µl 2i+LIF medium and dispersed to sin-
gle cells before keeping them on ice. Lastly, GFP fluorescence of single cells was measured using 




Table 2. Thermal profile 
of the qRT-PCR. cDNA 
samples in the qRT-PCR plate 
were run on the strategene  
MX3000P machine under this 
following condition. 
Step Time Temperature Note
First segment (1 cycle): 2 minutes 50℃
2 minutes 95℃
Second segment (40 cycles): 15 seconds 95℃
30 seconds 60℃ Measure fluorescence






Chapter 4. Effects of Vitamin C on rat ESC
 Rat ESCs were successfully derived from the blastocyst-stage embryo using the culture 
medium containing 2i plus LIF that promote self-renewal and prevent differentiation (Buehr et al., 
2008; Li et al., 2008). Since this landmark discovery, rESCs have been employed as an alternative 
and comparative model to mESC for the study of pluripotency and differentiation (Meek et al., 
2013; Chen et al., 2013). Although a range of cell signaling pathways involved in mESC mainte-
nance have been determined, much less has been discovered about rESC. Meek et al. (2013) 
demonstrated that the culture of rESC in the standard 2i + LIF medium is less reliable than mESC, 
displaying higher expression levels of differentiation genes. Interestingly, Esteban et al. (2010) re-
ported that Vitamin C improves the growth and formation of mouse induced pluripotent stem (iPS) 
cell colonies. Inspired by this study, we will document the effects of Vitamin C on rat ESCs.  
 To assay the pluripotent state and distinguish between differentiated and undifferentiated 
cells, we employed the Rex1-GFP reporter lines, in which GFP was placed under the control of the 
Rex1 promoter (Figure 4.1). As Rex1 is found in undifferentiated ESCs but lost in differentiated 
cells (Shi, Wang et al. 2006, Wang, Rao et al. 2006), their green intensity faithfully reports the ex-
pression of the pluripotency gene, Rex1, which allow us to monitor rESC self-renewal. (Meek, Wei 
et al. 2013). 
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Figure 4.1. Monitoring ESC self-renewal. (A): The schematic diagram shows that one of the Rex1 alle-
les was replaced by the fluorescent reporter GFP. Hence, when ESCs are undifferentiated, they express the 
Rex1 gene as well as GFP, whereas when the cells are differentiated, the GFP is not expressed. (B): Obser-
vation of the Rex1-GFP expression in the 2i culture media exhibited spontaneous differentiation as shown by 
the early endodermal marker GATA4 expression (Meek et al., 2015) Unpublished data from the Burdon lab. 





 To investigate the effect of Vitamin C on rat ESCs in culture, we examined the effect of Vit-
amin C on Rex-EGFP rESCs cultured for 5 days in 2i+LIF supplemented with and without 100µM 
Vitamin C.   
 Interestingly, when rESCs were treated with Vitamin C (Vc), there was a noticeable change 
in ESC morphology and colony number. In the standard rESC culture media (2i + LIF), there were 
sparse ESC colonies observed, whereas more round and compact ESC morphology was found in 
the presence of Vitamin C. Moreover, Vitamin C increased the total number of ESC colonies as 
well as their colony size (Figure 4.2). In addition, the level of Rex1 expression in Vc-treated cells 
was higher, than those cultured in the absence of Vc (Figure 4.2). This suggests that Vitamin C re-
duces differentiation and improves growth of rESC. 
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Figure 4.2. Vitamin C im-
proves ESC morphology. 
Bright-field images (upper 
panels) and fluorescence im-
ages of rESCs (lower panel) 
cultured in 2i + LIF in the ab-
sence of Vitamin C (left panel) 
or presence of Vitamin C 
(right panel) for 5 days (mag-
nification X10).
+ Vitamin C− Vitamin C
 
4.1. Growth 
 To measure cell growth, 500 ESCs were cultured in 2i + LIF medium on the feeder cells, 
under three different conditions: Mock (water), D-isoascorbic acid and L-ascorbic acid. At each day, 
the CyQUANT® cell proliferation assay selectively detected live cells. 
 According to the measurements of live ESC numbers (fluorescence), our three independent 
experiments demonstrated that the growth of rESCs is improved by Vitamin C. In Figure 4.3, Vita-
min C (Vc) appreciably increased the number of rat ESCs for 4 days, compared with Mock (control, 
water). Intriguingly, the Vc optical isomer, D-isoascorbic acid (Diso), lacking cofactor activity, did 
not improve rESC proliferation. Now, the intriguing question we can ask here is that ‘Is this growth 
pattern also observed in mouse ESCs?’ 
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Growth of three independent rat ESC 
lines. These rESCs are all male lines, 
and 500 cells were plated in quadrupli-
cate and cultured in 2i + LIF medium 
on the feeder cells in each well of 96 
well plates. Mock, water; Diso, 100µM 
D-isoascorbic acid; Vc, 100µM Vitamin 
C or L-ascorbic acid. Mean and SD of 
three experimental replicates.


















































Figure 4.4. Vitamin C does not improve growth of mouse ESCs.
Growth of three independent mouse 
ESC lines. These mESCs are all male 
lines, and 500 cells were plated in qua-
druplicate and cultured in 2i + LIF 
medium on feeder cells in each well of 
96 well plates. Mock, water; Diso, 
100µM D-isoascorbic acid; Vc, 100µM 
Vitamin C or L-ascorbic acid. Mean and 
SD of three experimental replicates.
 
 Surprisingly, rat and mouse ESCs did not respond to Vitamin C in the same way. There was 
no growth effects of Vitamin C in mouse ESCs (Figure 4.4). This strongly suggests that there is 
some unidentified mechanism in rat ESCs that we do not see in mouse ESCs. Furthermore, based 
on live cell fluorescence, it was observed that mouse ESCs grew much faster than rat ESCs. This 
rapid growth of mouse ESCs may indicate their shorter cell cycle (e.g. G1 phase), and may con-
tribute to why they are more stable in proliferation. It could also be due to poorer survival of rESC 
compared to mESC at low cell density. In addition, it appears that at 48h, the mESC growth sud-
denly accelerates. This could be the result of reaching an optimum cell density and the resulting 




 Rat ESCs are vulnerable to sporadic differentiation (Chen, Blair et al. 2013). According to 
the GFP fluorescence images of Figure 4.2, the Rex1-GFP reporter was brighter in the Vc-treated 
cells. This suggests that Vitamin C may decrease the spontaneous differentiation of rESCs, and 
promote self-renewal of undifferentiated cells, thereby leading them to a more naive pluripotent 
state. Based on this rationale, we investigated Vitamin C influences on ESC differentiation. 
 
 Rat ESCs are captured by preventing the MEK and GSK3β signalling pathways (Buehr, 
Meek et al. 2008, Li, Tong et al. 2008), so that they do not enter a differentiation process, but re-
main in a self-renewing, pluripotent state. To support this state, two inhibitors (2i), PD0325901 (PD) 
and CHIR99021 (CHIR or CH) are employed in the rESC culture media. Leukaemia inhibitory fac-
tor (LIF) is also incorporated in the standard rESC media (2i + LIF) to prevent differentiation and 
maintain Nanog, Oct4 and Klf4 (Buehr, Meek et al. 2008, Niwa, Ogawa et al. 2009). To test Vitamin 
C effects on differentiation, we induced differentiation by manipulating the rESC culture system 
(Figure 4.5). 
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Figure 4.5. Maintenance of rat ESC self-renewal. Two inhibitor system (2i) supports self-renewal 
of rESCs. FGF-MEK signalling is interrupted by the presence of PD0325901 (PD), which prevents differ-
entiation. Likewise, GSK3β is downregulated by CHIR99021 (CHIR), which retains self-renewal (Buehr et 








4.2.1. Vitamin C influence on MEK-induced differentiation 
 First of all, the MEK inhibitor, PD was removed in the standard 2i+LIF media to allow MEK-
induced differentiation. To maximise this MEK-induced differentiation, the pluripotency-facilitator 
LIF was also eliminated. 
 In Figure 4.6, when cultured in the standard ESC media (2i+LIF), there were many 
Rex1GFP-positive colonies observed with a round ESC morphology (2i + LIF, left panels in Figure 
4.6A), whereas, in the absence of PD, Rex1GFP fluorescence was greatly reduced (-PD, middle 
panels). Under this same condition, Vitamin C was added in order to see if Vitamin C can rescue 
those cells from MEK-induced differentiation (-PD + VC, right panels in Figure 4.6A). The Vc-treat-
ed ESCs were also differentiated in the absence of PD, as demonstrated by the loss of GFP. This 


















− PD    2i + LIF
+ Vc 
− PD
Figure 4.6. Vitamin C does not rescue ESCs from MEK-induced differentiation. In A and B, 
ESCs (135-4 cell line) were cultured in media containing 2i + LIF, 3 µM CHIR (-PD), and 3 µM CHIR + 100 
µM Vitamin C (-PD + Vc) for 4 days. Panel A shows bright-field and fluorescence images of the same cells 
(magnification X10). In panel B, the same rESC cultures were analysed (1x104 cells) by flow cytometry at 
day 4. Abbreviations: CHIR, CHIR99021; PD, PD0325901; LIF, leukaemia inhibitory factor; Vc, Vitamin C; 
SSC-H, side scatter pulse height (i.e. cell granularity or internal complexity).
 
 To qualitatively and quantitatively assay Vitamin C effects, the same cultures were analysed 
by qRT-PCR and flow cytometry respectively (Figure 4.6 and 4.7). In 2i+LIF, more than 80% ESCs 
showed RexGFP positive (left panels in Figure 4.6B), whereas when PD was eliminated, only 10% 
cells remained in a pluripotent state (middle panel). Surprisingly, the addition of Vitamin C shifted 
almost 100% ESCs to a differentiated state, leaving only 1% cells in a pluripotent state. Moreover, 
the results of all three independent ESC experiments showed the same pattern as demonstrated 
by the supplementary data (Figure S1-2). 
 We conducted qRT-PCR analysis for the differentiation marker, Gata4, on three indepen-
dent rESC lines (Figure 4.7). In the absence of PD, the level of Gata4 expression in rESCs in-
creased markedly, compared to those in the standard 2i + LIF media. Consistent with the flow cy-
tometry data presented above, the ESC differentiation represented by Gata4 expression level was 
not decreased in the presence of Vitamin C. Rather, this level was increased in two of the cell lines 
































































































2i + LIF - PD - PD 
+ Vc
2i + LIF - PD - PD 
+ Vc
2i  LIF - PD - PD 
+ Vc
Figure 4.7. Vitamin C does not downregulate MEK-induced Gata4 expression. Quantitative 
reverse transcriptase polymerase chain reaction (qRT-PCR) analysis for GATA4 transcripts. The graphs 
indicate the level of GATA4 expressions in three independent ESC lines (135-3, A; 135-4, B; 141-5, C). 
These ESCs were cultured in media containing 2i + LIF (red), 3 µM CHIR (-PD, blue), and 3 µM CHIR + 
100 µM Vitamin C (-PD + Vc, green) for 4 days. Abbreviations: CHIR, CHIR99021; PD, PD0325901; LIF, 
leukaemia inhibitory factor; Vc, Vitamin C.
CBA
 
4.2.2. Vitamin C influence on β catenin-induced differentiation 
 
 In addition to MEK-induced differentiation, Vitamin C effects were also examined on β 
catenin-induced differentiation. Canonically, rESC self-renewal is stabilised by MEK and GSK3β 
inhibitors (Buehr, Meek et al. 2008, Li, Tong et al. 2008). GSK3β inhibition by CHIR stabilises β 
catenin which antagonises the inhibitory activity of TCF3 on pluripotency genes (Chen et al. 2013). 
In the standard 2i+LIF medium, the level of β catenin activity is sufficient to inhibit TCF3 and pre-
vent repression of key pluripotency genes Nanog and Esrrb (Chen et al. 2013) (Figure 4.8A). Inter-
estingly, ESCs can also be maintained efficiently in 1i media (1µM PD) in which CHIR is absent 
(Meek et al. 2013). 
 However, when CHIR is added above the standard level (3 µM), lineage specification 
genes Brachyury and Cdx2 are markedly activated by high GSK3β inhibition, at the same time, the 
pluripotency genes Nanog, Rex1 and Esrrb are appreciably downregulated, causing ESC differen-
tiation (Chen, Blair et al. 2013, Meek, Wei et al. 2013). Therefore, we tuned β catenin activity by 
adding extra CHIR, which upregulates LEF1 (Chen, Blair et al. 2013), and deliberately established 

















Figure 4.8. Tuning of β catenin Activity for Induction of Differentiation. GSK3β is regulated by its in-
hibitor, CHIR. (A): At lower levels of β catenin activation, the dominant β catenin-mediated activity is abrogation of 
TCF3 transcriptional repression and maintenance of self-renewal. (B): At high levels, β catenin-mediated differentia-
tion appears to dominate via LEF1 transcriptional activation. (Chen et al. 2013; Meek et al. 2013). Abbreviations: 
CHIR, CHIR99021. (Created using information from different sources).
+ CH    2i + LIF
 
 
 Under 2i+LIF conditions, rESCs exhibited tight and round morphology of Rex1GFP-positive 
colonies, whereas when the concentration of CHIR was increased, most of the ESCs differentiated, 
as demonstrated by cell morphology and loss of GFP  (middle panels in Figure 4.9A). Vitamin C 
was administered to determine if Vitamin C can rescue those cells from CHIR-induced differentia-
tion. Interestingly, rESCs benefited from Vitamin C treatment, showing brighter and bigger Rex-
GFP-positive colonies. This suggests that Vitamin C prevents β catenin-induced ESC differentia-
tion, promoting self-renewal. 
 Quantitative analysis was performed by flow cytometry. In 2i+LIF, more than 80% of the 
cells maintained a high level Rex1-GFP fluorescence, but when CHIR concentration increased, the 




+ CH    2i + LIF
+ Vc 
+ CH
Figure 4.9. Vitamin C rescues ESCs from β catenin-induced differentiation. (A): rESCs (135-4 cell 
line) were cultured in media containing 2i + LIF or 2i with 5 µM CHIR (+CH), or 5 µM CHIR + 100 µM Vitamin C 
(+ CH + Vc) for 5 days. Panel A shows bright-field (upper) and fluorescence images (lower) of the same cells 
(magnification X10). (B): The same rESC culture conditions were used in another ESC line (135-3 line), and 

















population was expanded more than double by simply adding Vitamin C (Figure 4.9B). In addition, 
this Vitamin C plus CHIR experiment was repeated using another Rex1GFP reporter rESC line 
(Figure S3) as well as using two independent wild-type rESC lines (data not shown). All of which 
indicated the same pattern that Vitamin C prevents rESCs from CHIR-induced differentiation.   
 
 We performed qRT-PCR analysis to measure expression levels of ESC (Esrrb and Nanog) 
and differentiation markers (Gata4 and Brachyury). Under high GSK3 inhibition (+CH), the expres-
sion levels of the ESC markers, Esrrb and Nanog, were reduced by 60% and the expression of the 
differentiation markers, Gata4 and Brachyury increased compared to the standard 2i+LIF media. 
When treated with Vitamin C, rESCs upregulated Esrrb and Nanog, and downregulated Gata4 and 
Brachyury (Figure 4.10). This gene expression pattern was also confirmed in an independent ESC 























































































































Figure 4.10. Vitamin C upregulates Esrrb and Nanog, and downregulates Gata4 and 
Brachyury. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis for Esrrb, 
Nanog, GATA4 and Brachyury genes. The graphs indicate the level of gene expressions in ESCs (135-4 
line). These ESCs were cultured in media containing 2i + LIF (red) or 2i with 5 µM CHIR (+CH, blue) or 5 
µM CHIR + 100 µM Vitamin C (+CH +Vc, green) for 5 days. Abbreviations: CHIR, CHIR99021; PD, 
PD0325901; LIF, leukaemia inhibitory factor; Vc, Vitamin C.
Esrrb
2i + LIF + CH + CH 
+ Vc
Nanog Gata4 Brachyury
2i + LIF + CH + CH 
+ Vc
2i + LIF + CH + CH 
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4.2.3. D-isomer influence on CHIR-induced differentiation 
 As Vitamin C has both an antioxidant effect and a cofactor activity (Esteban, Wang et al. 
2010, Blaschke, Ebata et al. 2013, Monfort and Wutz 2013), we examined the effect of D-isoascor-
bic acid (the Vitamin C isomer that lacks cofactor activity) on β catenin induced differentiation. This 
will allow us to determine if the Vitamin C effect results from their antioxidant effects or cofactor 
activities. Here, rESCs were cultured under 2i + LIF or high CHIR conditions using D-isoascorbic 
acid and L-ascorbic acid (Vitamin C), and analysed by flow cytometry at day 4. 
 
 Consistent with the GSK inhibition data mentioned above (Figure 4.9), addition of extra 
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Figure 4.11. D-isoascorbic acid has little effect on β catenin-induced differentiation. (A): 
rESCs (123-2 RexGFP homozygous cell line) were cultured in media containing 2i + LIF, 5 µM CHIR + wa-
ter (Mock + CH), 5 µM CHIR + D-isoascorbic acid (Diso + CH), or 5 µM CHIR + 100 µM Vitamin C (Vc + 
CH) for 4 days. The A panels shows bright-field (upper) and fluorescence images (lower) of the same cells 
(magnification X10). (B): These cells were then analysed (1x104 cells) by flow cytometry at day 4. Abbrevi-
ations: CH (CHIR), CHIR99021; Mock, water; Diso, D-isoascorbic acid; Vc, L-ascorbic acid (Vitamin C).
 
nearly 50%). Likewise, Vitamin C (Vc) treatment prevented this differentiation leaving only 19% 
GFP-low cells. Compared with mock conditions, the addition of Vc increased the proportion of 
GFP-high cells by nearly 90% whereas the addition of D-isoascorbic acid (Diso, Vc isomer) only 
generated an increase of 25% (Figure 4.11). In short, D-ascorbic acid effects on CHIR-induced dif-
ferentiation are not pronounced as much as Vitamin C effects observed on them. This suggests 
that the effects mediated by Vc are not exclusively due to its anti-oxidant activity. 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4.2.4. Vitamin C influence on β catenin activity 
 It is clear that high GSK3β inhibition increases β catenin activity; β catenin binds to Lef1 
and Tcf1 to promote downstream activation of their target genes which include differentiation genes 
(Chen, Blair et al. 2013, Meek, Wei et al. 2013). Consequently, rESCs become differentiated by 
these lineage-specification factors (Chen, Blair et al. 2013). However, Vitamin C prevents this pro-
gression of rESC differentiation, suggesting that the Vc downstream targets revolve around this β 
catenin activity in the axis of Wnt/β catenin signalling pathway. Therefore, it is very tempting to 
measure the β catenin activity under Vitamin C and high CHIR conditions. This will identify whether 
Vitamin C exerts their influence on CHIR-induced differentiation by diminishing the β catenin activi-
ty.  
 To measure β catenin activity, the vector DNA plasmid containing a luciferase reporter gene 
and a recognition binding site of TCF/LEF (β catenin direct target) was inserted into ESCs. Hence, 
any active endogenous TCF complexes bind to this plasmid, and drives the expression of lu-
ciferase. Hence, luciferase activity is directly correlated with the β catenin activity. Here, rESC were 
cultured in 2i + LIF or 2i containing 6µM CHIR in the absence or presence of vitamin C for 2 days, 
and quantitatively analysed using a luminometer according to light emission. In addition, the ex-
pression level of the β catenin target, Axin2 was measured using qRT-PCR to determine the Vita-
min C effects on it. 
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Figure 4.12 Vitamin C targets beneath β catenin/TCF. (A): No distinct change in β catenin activity. 
Graph indicates ratio of TOPFlash:FOPFlash activity of rESCs cultured in 2i + LIF or 2i containing 6µM 
CHIR (+CH) for 2 days. Abbreviations: CH, CHIR99021. (B): Vitamin C does not markedly affect the Axin2 
expression level. qRT-PCR analysis for Axin2 gene. The graphs indicate the level of Axin2 expression in 
ESCs (135-3 cell line). These ESCs were cultured in media containing 2i + LIF (red) or 2i with 5 µM CHIR 
(+CH, blue) or 5 µM CHIR + 100 µM Vitamin C (+CH +Vc, green) for 5 days. Abbreviations: CHIR, 





























































































































































 The luciferase assay data demonstrated that, CHIR-induced β catenin activity, was not 
markedly reduced by Vitamin C. This indicates that Vitamin C reduces β catenin-induced differenti-
ation by targeting other factors, not directly β catenin activity. Furthermore, our qRT-PCR analysis 
for Axin2 suggested that Vitamin C has no pronounced effects on the expression level of the β 
catenin transcriptional target Axin2 (Figure 4.12). This suggests that Vitamin C acts indirectly on 





 In Figure 4.3, D-isoascorbic acid (the vitamin C optical isomer) lacking cofactor activity did 
not enhance proliferation of rat ESCs. This means that Vitamin C improves growth of rESCs 
through cofactor activities, and not exclusively via its antioxidant effects. Using the luciferase re-
porter assay, Meek et al. (2013) demonstrated that, in the canonical Wnt signalling pathways, its 
principal mediator β catenin shows a much higher activity in rat ESCs than mouse cells (Meek, Wei 
et al. 2013). It has been widely accepted that Wnt signalling pathways are involved in cell prolifera-
tion (Masckauchan, Shawber et al. 2005, Dejana 2010, Pei, Brun et al. 2012, Bilir, Kucuk et al. 
2013, Tian, Benchabane et al. 2016, Yang, Wang et al. 2016). Thus, the different β catenin activi-
ties may address the question why rat and mouse ESCs respond to Vitamin C differently.  
 Naïve ESC have a very low level of DNA methylation (Leitch, McEwen et al. 2013). Howev-
er, based on unpublished data from the Burdon lab in Edinburgh, rESC have higher expression 
levels of DNA methyltransferase-3a (Dnmt3a). Dnmt3a is known to increase DNA methylation lev-
els (Okano, Xie et al. 1998, Okano, Bell et al. 1999, Crider, Yang et al. 2012), and this may explain 
spontaneous differentiation and growth differences with mESC. Indeed, most genes generally be-
come silent as DNA methylation level increases (Bird 2002, Jones 2012, Rose and Klose 2014). 
We surmise that in rat ESCs, growth-facilitator genes are relatively hyper-methylated by inhibitors 
such as Dnmt3a, and thereby less accessible to their transcriptional enhancers. Therefore, Vitamin 
C may further reduce those methylation than mESCs whose methylation level is already lower.  
 However, this Vitamin C effect is also considered to be sex-dependent. Our unpublished 
data indicated that female rESC lines do not noticeably show the increased proliferation when Vit-
amin C is added. This highlights that other sex-dependent factors may also be involved in this Vit-
amin C influence. Interestingly, Ooi et al. (2010) discovered that female ESCs lose DNA meth-
ylation more rapidly, compared to male ESCs. This hypomethylation results from decreased levels 
of DNA methyltransferases in female ESCs, specifically DNMT3A and DNMT3B (Chen, Ueda et al. 
2003, Zvetkova, Apedaile et al. 2005, Ooi, Wolf et al. 2010). Taken together, females cells are 
hypo-methylated relative to male cells, and thus Vitamin C may reduce methylation in male cells to 
a level more comparable to those in female. 
 In addition, growth benefit of Vc is more pronounced at low cell density. This suggests that 
other factors, such as low levels of crucial autocrine factors, may affect this cell density-dependent 
growth. Autocrine factors, Activin and Nodal have been reported to affect ESC proliferation 
(Ogawa, Saito et al. 2007, Przybyla and Voldman 2012). There is also another report that an au-
tocrine factor, Cyclophilin A, is involved in density-dependent ESC growth (Mittal and Voldman 
2011). Hence we speculate that, as mouse ESCs grow faster, mouse ESCs produces more au-
tocrine factors, which may reduce the growth benefit of Vc, whereas less autocrine factors are 
generated by rat ESCs, thus Vc can largely increase the rat cell growth. If both mouse and rat cells 
are plated at the same density and the level of autocrine factors are similar, a different growth re-
sponse could be due to a different optimum cell density, and thus the different resulting response to 
autocrine factor signaling. It could also be that rESC survival is poorer than mESC at low cell den-
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sity. In addition, Vitamin C are generated by both mouse and rat ESCs themselves. There could be 
a difference in Vitamin C production, and hence they might respond to addition of Vitamin C differ-
ently. Taken all together, rat ESCs grow slower, but their growth can be improved by cofactor activi-
ties of Vitamin C. 
L-ascorbic acid (Vitamin C) effects on MEK-induced differentiation 
 Previously there was an argument that Vitamin C does not block ERK (MEK) activation dur-
ing somatic cell reprogramming to pluripotency (Shi, Zhao et al. 2010), suggesting that Vitamin C 
may function in an independent pathway. According to the flow cytometry data of three indepen-
dent experiments (Figure 4.6 and Figure S1-2), it is apparent that Vitamin C rather accelerates 
MEK-induced differentiation. Numerous published papers demonstrated that Vitamin C induces de-
methylation of DNA and histones with no cell-type specificity (Wang, Chen et al. 2011, Blaschke, 
Ebata et al. 2013, Monfort and Wutz 2013, Yin, Mao et al. 2013, Soufi 2014, Gustafson, Yang et al. 
2015, Eid and Abdel-Rehim 2016). Building on this knowledge, we hypothesise that Vitamin C may 
open up the heterochromatin of silent genes, including differentiation genes as well as pluripotency 
factors (Soufi, Donahue et al. 2012, Soufi 2014, Becker, Nicetto et al. 2016). Hence, in response to 
Vitamin C, ESCs may likely switch any genes on randomly, but some of them may be activated ac-
cording to their current cell states and their circumstances. Because our ESCs shifted to a differen-
tiated state by MEK signals, hyper-methylated chromatin of differentiation-promoting genes (e.g. 
GATA4) may have become more accessible to their transcriptional activators, and Vitamin C may 
simply have enhanced differentiation. Therefore, we see more differentiated ESCs in the Vitamin C 
condition (Figure 4.6).  
L-ascorbic acid (Vitamin C) effects on β catenin-induced differentiation 
 In Figure 4.10, our findings on up-regulation of Nanog and its direct target Esrrb by Vitamin 
C, support the published data that Vitamin C functionally compensates for Nanog deficiency 
(Schwarz, Bar-Nur et al. 2014). Furthermore, β catenin is not only known to reduce the repressive 
action of TCF3 on pluripotency genes (Wray, Kalkan et al. 2011), but also interacts with Lef1 to ac-
tivate transcription of their target genes including early differentiation genes; CHIR stabilises β 
catenin and upregulates LEF1 (Chen, Blair et al. 2013, Ho, Papp et al. 2013, Meek, Wei et al. 
2013). Hence it is easy to speculate that Vitamin C enables ESCs to tolerate high levels of β 
catenin activity, and consequently we see higher pluripotency gene expression.  
 In contrast to the results from the MEK-induced differentiation, Vitamin C suppresses β 
catenin-induced differentiation. This highlights that there are unknown interactions going on be-
tween Vitamin C and β catenin signalling. Indeed, two years ago, there was an analogous demon-
stration in mouse induced pluripotent stem cells (iPSCs) (Bar-Nur, Brumbaugh et al. 2014). Vitamin 
C and GSK3β inhibition do function synergistically during induction of pluripotency, by promoting 
the activation of pluripotency factors involved in a self-sustaining pluripotent state, such as, Nanog, 
Sox2, Zfp42, Zfp296, and miR-290-295  (Bar-Nur, Brumbaugh et al. 2014). It then raises a subse-
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quent question that, ‘which Vitamin C downstream effectors can support rESC self-renewal under 
CHIR-induced differentiation?’. 
 It is well-known that Vitamin C has two different functions (Monfort and Wutz 2013); one is 
an antioxidant effect, and the other action is a cofactor activity for DNA and histone demethylases 
such as TET and KDM families (Esteban, Wang et al. 2010, Blaschke, Ebata et al. 2013, Monfort 
and Wutz 2013). To determine by which of these mechanisms Vc mediates its effects, we also 
tested the influence of D-isoascorbic acid (the Vitamin C isomer that lacks cofactor activity, but re-
tains antioxidant activity), on CHIR-induced differentiation of rESCs. This would answer the ques-
tion whether the Vitamin C influence stems from their antioxidant effects or cofactor activities. 
D-isoascorbic acid (Vc isomer) effects on β catenin-induced differentiation 
 There was some response of rESCs to D-isoascorbic acid which we expected, since this Vc 
isomer simply reflects a mirror structure of Vitamin C (Monfort and Wutz 2013). Therefore, this op-
tical difference in structure may only contribute to their affinity differences with regard to associat-
ing with other target enzymes (Wilson and Dixon 1989, Monfort and Wutz 2013). That is, D-
isoascorbic may still retain some cofactor activity, but reduced relative to the L-form (Vitamin C). 
Alternatively it suggests that the effects of Vc may be a combination of antioxidant and co-factor 
effects. Additionally, in accordance with other published data (Esteban, Wang et al. 2010, 
Blaschke, Ebata et al. 2013, Monfort and Wutz 2013), our results indicate that Vitamin C influence 
on β catenin-induced differentiation mostly relies on their enzymatic cofactor roles (Figure 4.11). 
Hence, we surmise that Vitamin C epigenetically facilitates activation of genes involved in ESC 
self-renewal, by acting as a cofactor (electron donor) for those Fe(II)-dependent enzymes. These 
enzymes are usually DNA and histone de-demethylases, such as TET and KDM families (Shi, 
Zhao et al. 2010, Monfort and Wutz 2013, Pera 2013). 
Vitamin C influence on β catenin activity 
 β catenin activity is involved in both Tcf3 and Lef1 regulation (Chen, Blair et al. 2013). Op-
timal GSK3β inhibition mainly reduces the inhibitory effects of Tcf3 on pluripotency genes (e.g. 
Nanog and Esrrb) by decreasing β catenin activity; this result promotes ESC self-renewal (Chen, 
Blair et al. 2013, Meek, Wei et al. 2013). However, high GSK3β inhibition predominantly facilitates 
LEF1-mediated differentiation (Chen, Blair et al. 2013), which is correlated with up-regulation of 
Brachyury and Axin2, and down-regulation of Esrrb and Nanog (Figure 4.10). According to the data 
in Figure 4.12, Vitamin C does not affect β catenin activity directly, indicating that Vitamin C targets 
are present beneath β catenin. Interestingly, Brachyury was down-regulated in the presence of Vit-
amin C, whereas the Axin2 expression level was not markedly changed by Vitamin C. This indi-
cates that the β catenin/TCF/LEF activity corresponds to Axin2 expression, while Brachyury may 
be repressed indirectly by different factors, for example, pluripotency factors such as Nanog and 
Esrrb.  
 To interrogate the role of potential downstream candidates on Vc-mediated activity, siRNA 
knockdown of target mRNA transcripts was employed. Previously, siRNA-mediated knockdown 
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was reported as an efficient approach to degrade target mRNAs (Meek et al. 2013). Thus, siRNA 
transfection was incorporated in our experiments to determine if knockdown of DNA and histone 




Chapter 5. Establishing Vitamin C target assay
 The results in the previous chapter show that Vitamin C suppresses CHIR-induced ESC 
differentiation. We therefore plan to use this GSK3β inhibition assay to interrogate potential down-
stream targets of Vitamin C. In order to identify the Vitamin C targets that interfere with the effects 
of high β catenin activity, siRNA knockdown was performed. siRNA transfection has previously 
been reported as a reliable tool to knockdown mRNA targets in rESCs (Meek, Wei et al. 2013). In 
this chapter, we refine the siRNA transfection, differentiation and Vc conditions to increase the like-
lihood of identifying targets involved in Vc-mediated inhibition of CHIR induced differentiation. 
5.1 Validation of siRNA activity using Lef1 knock-down 
 To demonstrate the efficiency of this approach, siRNA activity was first validated to target 
the Lef1 mRNA, because LEF1 is considered as a critical effector in driving ESC differentiation in 
high CHIR culture conditions (Chen, Blair et al. 2013, Ho, Papp et al. 2013). We transfected siRNA 
for LEF1 (50nM) into Rex-EGFP cells treated with 6µM CHIR and analyzed these cells using flow 














 In Figure 5.1, the 2i + LIF condition generated round and tight ESC colonies with a Rex1-
GFP positive population of approximately 90%. Additional CH treatment shifted the majority of 
Rex1-GFP positive cells to a differentiated state, exhibiting a 60%GFP-negative population. When  
ESCs cultured in high CHIR were transfected with Lef1 siRNA, they remained in a pluripotent 
state, with 85% of the cells retaining Rex-GFP expression. This experiment was repeated using a 
control siRNA (negative siRNA) which had no effect and additionally demonstrated that negative 
siRNAs have no influence on rESC differentiation, as shown by the supplementary data (Figure 
S6). These results clearly demonstrated siRNA knockdown and flow cytometry as a valid assay for 
assessment of the potential Vc targets.  
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Figure 5.1 Lef1 siRNA effectively blocks ESCs from CHIR-induced differentiation. (A): 
Bright-field (upper) and fluorescence (lower) images (magnification X10) of rESCs (135-4) cultured in me-
dia containing 2i + LIF or 2i with 6 µM CHIR (+CH) or 6 µM CHIR + 50 nM Lef1 siRNA (Lef1 siRNA + CH) 
for 5 days. (B): The same cells were then analysed (1x104 cells) by flow cytometry at day 5. Abbreviations: 
CHIR/CH, CHIR99021.
 
5.2. Titration of CHIR concentration 
 To determine the optimal concentration of CHIR (GSK inhibitor), rat ESCs were cultured in 
media containing 2i + LIF or 2i with 5 µM CHIR, 7 µM CHIR, or 9 µM CHIR in the absence or pres-









Figure 5.2. ESCs are efficiently differentiated and rescued by Vc at 7µM CHIR. (A): Fluores-
cence images (magnification X10) of rESCs (123-2 RexGFP homozygous) cultured in media containing 2i 
+ LIF or 2i with 5 µM CHIR, 7 µM CHIR, or 9 µM CHIR in the absence or presence of Vitamin C for 3 days. 
(B): These cells were then analysed (1x104 cells) by flow cytometry at day 3. Abbreviations: CH (CHIR), 



























 In the 2i + LIF media, the ESC cultures contained approximately 90% RexGFP-positive and 
5% negative cells (Figure 5.2). When the cultures were treated with 5µM, 7µM and 9µM CHIR 
each, the GFP negative populations gradually increased, indicating 15%, 46%, and 54%, respec-
tively. When Vitamin C was administered, these Rex1 negative populations decreased showing 
15% down to 6%, 46% down to 29%, and 54% down to 40%, respectively. This corresponds to a 
level of suppression of differentiation by Vitamin C of roughly 8%, 17%, and 15%, suggesting that 
Vitamin C was most effective in 7µM CHIR media. Hence, this CHIR concentration (7µM) was cho-
sen due to pronounced differentiation and also rescued by Vitamin C. 
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5.3. Titration of Vitamin C concentration 
 To determine the optimal concentration of Vitamin C, rat ESCs were cultured in media con-
taining 2i + LIF or 2i (7µM CHIR) along with 0µM, 50µM, 100µM, 200µM or 400µM Vc for 3 days. 
 
 In the 2i+LIF media, 88% Rex-positive and 9% Rex-negative cells were observed, 
whereas, in the presence of CHIR, 17% pluripotent and 72% differentiated populations 
were detected (Figure 5.2). The GFP-negative cell population decreased in relation to Vc 
concentration up to 100µM, but with no marked benefit at concentrations greater than 
100µM. Based on this experiment, 100µM Vitamin C is effective in reducing CHIR-induced 







Figure 5.2. 100µM Vitamin C is effective in preventing CHIR-mediated differentiation. rESCs 
(123-2 RexGFP homozygous) cultured in media containing 2i + LIF or 2i (7µM CHIR) along with 0µM, 
50µM, 100µM, 200µM or 400µM Vc for 3 days. These cells were analysed (1x104 cells) by flow cytometry at 
day 3. Abbreviations: CH (CHIR), CHIR99021; Vc, L-ascorbic acid (Vitamin C).
2i + LIF CH + 0µM Vc CH + 50µM Vc










 In summary, we have validated siRNA activity by transfecting rESCs with Lef1 siRNA, as 
demonstrated by the result that most ESCs are rescued from CHIR-induced differentiation by Lef1 
knockdown. In addition, CHIR concentration was titrated which demonstrated that 7µM CHIR is 
efficient to get ESCs differentiated, which can be delayed by Vc. Finally, titration of Vitamin C con-
centration was performed and revealed that 100µM Vc is the optimal concentration to prevent ESC 
differentiation caused by GSK3β inhibition. 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Chapter 6. Roles of TET and KDM enzymes in Vitamin C effects
 We discovered that Vitamin C promotes growth of rat ESCs, but not mouse ESCs. This 
growth effect is not observed upon treatment with D-isoascorbic acid (Vc isomer deficient in cofac-
tor activity). In addition, Vitamin C blocks β catenin-induced differentiation, but not MEK-induced 
differentiation. In rESC cultures with high β catenin activity, Vitamin C upregulates pluripotency-as-
sociated genes and downregulates differentiation-related factors. Administration of D-isoascorbic 
acid had little effect on this β catenin-induced differentiation. This result suggests that Vitamin C 
influences on the ESC differentiation mostly rely on enzymatic cofactor activities (Esteban, Wang 
et al. 2010, Blaschke, Ebata et al. 2013, Monfort and Wutz 2013). Therefore, we speculate that Vi-
tamin C epigenetically reconfigures chromatin structures and promotes activation of genes in-
volved in ESC self-renewal, by acting as a cofactor (electron donor) for those iron-possessing en-
zymes. According to recent publications these enzymes are most likely to be DNA and histone de-
demethylases (e.g. TET and KDM families) (Shi, Zhao et al. 2010, Monfort and Wutz 2013, Pera 
2013). 
 
 Various reports argue that Vitamin C induces pluripotency acting through TET1 and TET2 
that prevent gene silencing by reconfiguring DNA structures (Blaschke, Ebata et al. 2013, Chen, 
Guo et al. 2013, Yin, Mao et al. 2013, Gustafson, Yang et al. 2015). Likewise, induction of pluripo-
tency is also significantly improved by Vitamin C-dependent enzymes, such as KDM2A and KD-
M2B, which are involved in demethylation of H3K36me1/me2 (Tsukada, Fang et al. 2006, He, 
Kallin et al. 2008, Wang, Chen et al. 2011) in Figure 6.1. 
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Figure 6.1. Potential downstream pathways 
employed by Vitamin C. Vitamin C acts as a 
cofactor for Fe(II)-dependent enzymes. In the 
presence of iron in the Fe(IV) state, Vitamin C pro-
duces two electrons to switch the iron to the Fe(II) 
state of iron-possessing enzymes. We hypothesise 
that TET1/2 activated by Vitamin C may support 
rESCs in a naïve state by de-methylating DNA 
(Blaschke et al. 2013). In addition, KDM2a/2b up-
regulated by Vitamin C might facilitate rESCs in a 
ground state by reducing histone methylation 












 To determine whether TET1/2 and KDM2A/2B are mediators of Vitamin C activity in rESCs,  
siRNA knockdown of their transcripts was performed. This will identify whether these enzymes are 
involved in preventing CHIR-induced differentiation. To illuminate this, we planned to use siRNAs 
as a gene-silencing tool (Figure 5.1), as previously demonstrated (Chen et al. 2013, Meek et al. 
2013). Therefore, the interfering activity of commercially available siRNA sequences specific to 
TET1/2 and KDM2A/2B, were assessed using qRT-PCR analysis. 
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6.1. Validation of siRNA activity using Tet1/2 and Kdm2a/2b 
 siRNA activity was validated and the optimal concentration determined following transient 
transfection into rESC and subsequent analysis of mRNA level by qRT-PCR. As shown by the sup-
plementary data (Figure S7), we discovered that approximately 50µM siRNA generates efficient 
knockdown in most of the target genes. We screened two different siRNA sequences specific for 
each target individually and in combination to identify the condition which produced the greatest 
knockdown. 
 To validate siRNA activity, ESCs were transfected with the appropriate siRNAs and cultured 





















































































































































































































 Two independent siRNAs were tested for each target. For Tet1, an equivalent knockdown of 
70-80% was observed with both siRNAs whether independently or in combination (Figure 6.1A). 
For Tet2, optimum knockdown of 50% was achieved using siRNA 1, whereas Tet2 mRNA levels 
were not reduced by siRNA 2, and only by approximately 30% with both TET2 siRNAs in combina-
tion. (Figure 6.1B). For Kdm2a, a reduction of 35-40% was detected with both siRNAs indepen-
dently, while both siRNAs in combination degraded 50% mRNA transcripts (Figure 6.1C). For Kd-
m2b, a knockdown of 45-55% was measured with both siRNAs whether independently or in com-
bination (Figure 6.1D). Therefore, we decided to use siRNAs independently that exhibited the best 
knockdown level. That is, siRNAs of Tet1, Tet2, Kdm2a and Kdm2b degraded the mRNAs by 70%, 
50%, 40% and 55%, respectively. 
 We validated siRNA activity of each gene at day 3 (Figure 6.1A - D). However, we later dis-
covered that all siRNA activities completely perish on the following day (day 4). In Figure 6.1E, al-
though 75% mRNA knockdown was observed under Tet2 siRNA at day 3, by day 4 no siRNA activi-
ty was observed. This suggests that siRNA knockdown starts to disappear prior to day 4. Indeed, 
during the validation of siRNA activity of Tet1/2 and Kdm2a/2b (Figure 6.1), one of our qRT-PCR 
results presented little mRNA knockdown at day 3 (data not shown). Hence, it might be difficult to 
see the knockdown clearly between day 3 and day 4. 
 58
Figure 6.1 Validation of potential target siRNA activity. (A - D): Quantitative reverse transcriptase 
polymerase chain reaction (qRT-PCR) analysis for Tet1, Tet2, Kdm2a and Kdm2b mRNAs. The graphs indi-
cate the level of gene expressions in rESCs (DAK31 male) transfected with the appropriate siRNAs for 24 
hours then subsequently cultured in media containing 2i + LIF for 3 days. Two different siRNAs were de-
signed for each gene, and used individually or combined together. (E): Duration of siRNA activity. qRT-PCR 
analysis for Tet2 mRNA. The graphs indicate the level of gene expressions in rESCs (135-4 RexGFP het-
erozygous) transfected with the appropriate siRNAs for 24 hours then subsequently cultured in media con-
taining 2i (6µM CHIR) and 2i (5µM CHIR) for 3 and 4 days, respectively. Abbreviation: negative siRNA, Con-
trol siRNA.
 
6.2. siRNA Knockdown of Tet1/2 and Kdm2a/2b 
 If these enzymes mediate Vc effects on CHIR-induced differentiation, then we ex-
pect that Tet and Kdm siRNAs would, at least partly, hinder the Vitamin C rescue from 
those differentiation. 
 To conduct siRNA knockdown, rESCs were transfected with the appropriate siRNAs 
for 24 hours and subsequently cultured in media containing 2i+LIF or 2i contains 7 µM 





















































 In Figure 6.2, in the presence of negative siRNA, the 2i + LIF ESC cultures contained 82% 
Rex1-positive cells, whereas only 30% undifferentiated population was found in the high CHIR me-
dia. When Vc was added, 57% cells remained in a pluripotent state, indicating a 1.87 fold rescue 
by Vc. For Tet1 and Tet2, an equivalent ESC population of 70-75% was measured in 2i+LIF with 
both siRNAs independently, while a Rex1-GFP positive population of 25-26% remained in high 
CHIR cultures with both siRNAs. This indicates loss of Rex1-GFP observed in all high CHIR condi-
tions. Upon treatment of Vitamin C, a pluripotent cell population of 45-52% was maintained with 
both siRNAs indicating a1.8-2.0 fold rescue by Vitamin C that is comparable with the –ve siRNA. In 
conclusion, knockdown of Tet1 and Tet2 has no significant involvement in Vc-mediated activity. 
This indicates Tet1 and Tet2 may not be the downstream targets of the Vitamin C effects. 
 In order to validate Tet knockdown, qRT-PCR analysis was performed. Upon treatment of 
Tet1 siRNA, there was no reduction in Tet1 mRNAs, except 30% knockdown in the 2i + LIF condi-
tion. Likewise, only 30% knockdown was observed in 2i+LIF conditions with Tet2 siRNA. Interest-
ingly, the level of Tet2 expression was greatly reduced in all CH+ conditions, suggesting that ex-
pression of the Tet2 gene may be down-regulated under β catenin induced differentiation. 
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Figure 6.2. Effects of Tet1 and Tet2 knockdown. (A): Bright-field and fluorescence images (magni-
fication X10) of rESCs (123-2 RexGFP homozygous) transfected with the appropriate siRNAs for 24 hours 
and subsequently cultured in media containing 2i + LIF, 2i (7 µM CHIR) or 2i (7 µM CHIR) + 100µM Vitamin 
C for 3 days. (B): These cells were analysed (1x104 cells) by flow cytometry at day 3. (C): Validation of 
siRNA knockdown of Tet1 and Tet2. qRT-PCR analysis for Tet1 and Tet2 mRNAs. The graphs indicate the 
level of gene expressions in those transfected rESCs. Abbreviations: CH (CHIR), CHIR99021; Vc, L-ascor-
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 To knockdown the potential Vc targets Kdm2a & b, rESCs were transfected with the 
specific siRNAs for 24 hours and cultured in media containing 2i+LIF or 2i contains 7 µM 
CHIR with or without 100µM Vitamin C for 3 days. 
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 Despite Kdm2a and Kdm2b knockdown, an equivalent Rex1-EGFP positive popula-
tion of 76% was observed in 2i+LIF with both siRNAs independently (Figure 6.3). In high 
CHIR conditions, the pluripotent cell population reduced to only 15-17% with both siRNAs. 
In the presence of Vc, the Rex1-GFP positive population increased to 37-40% with both 
siRNAs, compared to 57% with the –ve siRNA. This indicates a 2.3-2.5 fold rescue by Vit-
amin C upon Kdm2a or Kdm2b knockdown, compared with only 1.87 fold with the –ve siR-
NA. Indeed, we expected that Vc-rescued ESC population would be diminished by a lack of 
expression levels of those potential Vc target genes. Interestingly, however, Kdm2 knock-
down enhanced the differentiation in high CHIR conditions, suggesting that Kdm2 is a neg-
ative regulator of differentiation. Vitamin C rescued more ESC populations, as knockdown 
of Kdm2a and Kdm2b mRNAs decreased higher percentage of pluripotent cells in high 
CHIR cultures, when compared to the CH+ cultures containing negative siRNAs. The fact 
that the increase in differentiation is corrected by addition of Vc indicates that Kdm2 does 
not mediate Vc effect. 
 In order to validate our results above, qRT-PCR analysis for Kdm2a and Kdm2b 
genes was performed. In the presence of Kdm2a siRNA, there was no significant mRNA 
reduction in all high CHIR cultures, and only 30% knockdown in the 2i + LIF conditions. In 
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Figure 6.3. Effects of Kdm2a and Kdm2b knockdown. (A): Bright-field and fluorescence images 
(magnification X10) of rESCs (123-2 RexGFP homozygous) transfected with the appropriate siRNAs for 24 
hours and subsequently cultured in media containing 2i + LIF, 2i (7 µM CHIR) or 2i (7 µM CHIR) + 100µM 
Vitamin C for 3 days. (B): These cells were analysed (1x104 cells) by flow cytometry at day 3. (C): Valida-
tion of siRNA knockdown of Kdm2a and Kdm2b. qRT-PCR analysis for Kdm2a and Kdm2b mRNAs. The 
graphs indicate the level of gene expressions in those transfected rESCs. Abbreviations: CH (CHIR), 
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addition, the expression levels of Kdm2b were increased in all CH+ conditions by at least 




Issues of siRNA activity and duration 
 To knockdown target genes, siRNA was incorporated in our experiments. RNA interference 
(RNAi) system is found in eukaryotes to defend against RNA viruses (Hannon 2002). In the pres-
ence of a RNA viral genome, which is double-stranded RNA (dsRNA), a nuclease Dicer cleaves 
dsRNA into short fragments (short interfering RNA, siRNA) (Kim and Rossi 2008, Davidson and 
McCray 2011). Subsequently, RISC (RNA-induced silencing complex) binds this siRNA, and sepa-
rates the strands (Kim and Rossi 2008, Davidson and McCray 2011). Using this siRNA strand, 
RISC then base-pairs with and degrades mRNA of infecting RNA virus (Hannon 2002). 
 The benefits of using siRNA is that it is not constitutive, and there is no need to select mu-
tant cell lines (Wilson and Doudna 2013, Barrangou, Birmingham et al. 2015). As for siRNA trans-
fection, negatively charged siRNAs combine with positively charged lipid vesicles (liposomes) to 
produce complexes of liposome-siRNAs (Shen, 2016). Since these complexes have net positive 
charges, they allow the cells to be transfected with the siRNAs in cell cultures (Shen, 2016). Sub-
sequently, siRNAs induce degradation of target mRNAs during the first 24 hour-incubation (Petroc-
ca and Lieberman 2011). 
 When we transfected rESCs with Lef1 siRNAs, the degree of knockdown was good enough 
to maintain ESC self-renewal. We also clearly validated siRNA knockdown of Tet1, Tet2, Kdm2a 
and Kdm2b in rESCs cultured under 2i + LIF conditions. However, we detected only limited mRNA 
reduction when we conducted transfection of siRNAs in the CHIR/Vc treated cells (Figure 6.2 and 
6.3). Indeed, the degree of knockdown could be affected by a number of variables, for example, 
state of cells, cell culture media, duration of siRNA incubation, cell number, amount of transfection 
reagent, and amount of donor DNA (Hannon 2002, Agrawal, Dasaradhi et al. 2003, Kim and Rossi 
2008, Davidson and McCray 2011, Wilson and Doudna 2013).  
 Practically, there are several ways we can improve efficiency of transfection and siRNA 
knockdown. In our experiments, we transfected ESCs with relevant siRNAs in each culture condi-
tion, in an attempt to facilitate the knock-down during the period of CHIR induced differentiation. 
This may have introduced different levels of knockdown in treatments despite containing the same 
siRNAs. Therefore, it would also be worthwhile to determine if transfecting ESCs cultures with the 
same siRNAs and then subdividing them into the appropriate culture conditions could reduce any 
variability in degree of knock-down. In this way, we can remove the different efficiency between cell 
culture conditions containing the identical siRNAs. However, the problem involved in this experi-
ment is that we needed to culture the cells from day 0 in different conditions (2i+LIF culture and 
high CHIR culture with Vc or without Vc). 
 In addition, our experiment confirmed siRNA knockdown at day 3, but demonstrated no 
knockdown at day 4 (Figure 6.1E). This highlights that siRNA activity is transient and may last just 
for a couple of days, as the cells divide (Barrangou, Birmingham et al. 2015). Thus, we might not 
see the knockdown clearly between day 3 and day 4, although optimal knockdown may have oc-
curred in the first 48h (Figure 6.5). Furthermore, the experimental time-window for assessing phe-
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notypes is limited by the duration of the transient siRNA activity. Indeed, our experiment required at 
least 3 to 4 days for both Vitamin C and high CHIR effects clearly to be seen in ESCs. Although we 
validated siRNA activity and observed Vitamin C effects at day 3, this 72 hour-duration was too 
short for ESCs to be fully influenced by Vitamin C and differentiated by CHIR, because there is a 
delay in phenotypic expressions between DNA, mRNA and proteins. At the same time, the three/
four day culture was, on the other hand, the limit to observe sustained suppression of siRNA target 
activity. One of the approaches we can address this issue is to transfect cells with siRNAs every 
two days (Sridharan, Gonzales-Cope et al. 2013, Barrangou, Birmingham et al. 2015). In this way, 
we can retain siRNA knockdown throughout the experiments and can secure enough duration for 
Vc and CHIR treatments, although other technical variables should also be considered. 
 Since the discovery of siRNAs (Hamilton and Baulcombe 1999, Elbashir, Harborth et al. 
2001), this approach has been reported to posses some limitations. When a high levels of of siR-
NAs are introduced, they can be recognised as a viral by-product and activate innate immune re-
sponses; consequently non-specific effects may occur (Whitehead, Dahlman et al. 2011). In addi-
tion, siRNA may cause off-target effects (Birmingham, Anderson et al. 2006, Shen, Sun et al. 
2012). Moreover, especially as for targeting enzymes, siRNA knockdown should be carefully con-
sidered to use them. It has not been discovered how much enzyme activity is required for rat 
ESCs. It can be possible that just 10% activity may be enough for rESCs to respond normally (Bar-
rangou, Birmingham et al. 2015). siRNA can also affect the viability of transfected cell cultures 
(Doudna and Charpentier 2014; Arunkumar, 2015). 
 To overcome these limitations, CRISPR-Cas9-mediated genome editing can be employed 
(Jinek, Chylinski et al. 2012). This CRISPR system originates from the bacterial immune system as 
it can defend bacteria against invading DNA and RNA viruses by destroying their viral genomes 
(Barrangou, Birmingham et al. 2015). In the presence of virus genome, the CRISPR domains on 
the bacterial chromosome are transcribed into RNA molecules, which are subsequently cleaved 
into segments by certain endonuclease CAS proteins (Doudna and Charpentier 2014). When this 
CRISPR RNA segment bound to other CAS enzymes, recognises virus RNA or DNA (target 












Figure 6.5 Hypothetical model of siRNA activi-
ty duration. Under the optimal ESC conditions, 
genes express consistently at the normal mRNA level. 
However, after siRNA transfection, mRNA level de-
creases, and its knockdown level disappears between 
post-transfection day 3 and 4, depending on the vari-
ous factors such as duration of siRNA incubation, cell 
number, amount of transfection reagent and amount of 
donor DNA (Hannon 2002; Agrawal, et al. 2003; Kim 
and Rossi 2008; Davidson and McCray 2011; Wilson 
and Doudna 2013).
 
Cong, Ran et al. 2013, Jinek, East et al. 2013, Mali, Yang et al. 2013). This bacterial immune sys-
tem has been repurposed for gene editing in mammalian cells using a Cas9 nuclease that cleaves 
DNA flanked by a PAM (protospacer-adjacent motif) with the help of a single guide RNA (sgRNA) 
or a CRISPR RNA (crRNA) and a trans-activating crRNA (Brouns, Jore et al. 2008, Garneau, 
Dupuis et al. 2010, Deltcheva, Chylinski et al. 2011, Gasiunas, Barrangou et al. 2012, Jinek, 
Chylinski et al. 2012). This technology contains multiple advantages over RNA interference-based 
gene silencing (e.g. shRNA and siRNA). For example, the CRISPR-Cas9 based genome engineer-
ing can knockout target genes by disrupting a genes reading frame (Barrangou, Birmingham et al. 
2015, Chu, Rios et al. 2015). The Cas9 nuclease generates a double-strand break (DSB) in the 
intended target DNA (Jinek, Chylinski et al. 2012, Cong, Ran et al. 2013, Jinek, East et al. 2013, 
Mali, Yang et al. 2013). The DSB can be repaired by non-homologous end joining (NHEJ) or ho-
mology-directed repair (HDR) (Chapman et al. 2012). The NHEJ creates unpredictable small inser-
tions or deletions, resulting in a potential inactivating mutation in the targeted DNA, whereas the 
HDR is utilised for precise and predictable modifications at the targeted loci (Barrangou, Birming-
ham et al. 2015). The Cas9 endonuclease can also act as a nickase that cleaves single-stranded 
DNA when one of its two nuclease domains HNH and RuvC-like is inactivated (Bolotin, Quinquis et 
al. 2005, Haft, Selengut et al. 2005, Makarova, Grishin et al. 2006, Barrangou, Birmingham et al. 
2015). In addition, this system can be engineered to function as a repressor to suppress a target 
gene for a longer period of time (Doudna and Charpentier 2014, Barrangou, Birmingham et al. 
2015), hence removes a requirement for the every two day delivery of siRNAs (Arunkumar, 2015). 
 In contrast to RNAi mechanism employed by eukaryotes, CRISPR/Cas9 systems lack in 
eukaryotes (Doudna and Charpentier 2014). This makes CRISPR system more important, provid-
ing different applications in that competition with endogenous eukaryotic signalling is problematic. 
In particular, utilising RNAi to down-regulate genes that are responsible for the RNAi signalling it-
self (for example, Dicer) can generate data which are complicated to analyse, because of unpre-
dictable direct and indirect influences involved (Doudna and Charpentier 2014). Possibly, any RNA 
molecules utilised to reduce the expression levels of certain genes might compete with endoge-
nous RNA-dependent gene expression. However, CRISPR-Cas9 can permanently edit the genetic 
code and regulate gene expression transcriptionally or post-transcriptionally; hence, this offers a 
great versatility in utilising alternatives, while RNAi is mainly restricted to reducing expression of 
genes (Doudna and Charpentier 2014). Limitation of CRISPR/Cas9 mutagenesis is that it cannot 
be used for essential genes, since the mutated clones cannot survive (Singh, Schimenti et al. 
2015). Taken together, although RNAi system has been widely used for gene silencing over many 
years, several issues such as off-targeting and incomplete and transient knockdowns are the limi-
tations of this technology (Moore, Guthrie et al. 2010, Davidson and McCray 2011), and CRISPR 
systems can overcome these issues as they posses multiple advantages over RNAi-based gene 
silencing (Harrison, Jenkins et al. 2014). 
Knockdown of Tet1/2 and Kdm2a/2b 
 Although the degree of target gene depletion was limited in the CHIR/Vc treated cells, 
overall Tet and Kdm siRNAs degraded mRNAs. In the test transfections, we have demonstrated 
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marked reduction of target mRNA transcripts (Figure 6.1), however, in the actual experiments, 
when the effects of knockdown on the Vc-treated cells were measured after 3 days, we did not de-
tect similar kind of knockdown phenotypes (Figure 6.2 and 6.3). This is because siRNA is transient, 
as demonstrated by data in Figure 6.1E; the level of knockdown disappears between day 3 and 
day 4. In addition, in the experimental knockdown, the high CHIR conditions or addition of Vitamin 
C may affect the level or duration of knockdown, compared with 2i+LIF conditions. In Figure 6.2C 
and 6.3C, while all four target siRNAs have clearly knocked down mRNAs in all 2i + LIF cultures, 
some of the mRNA reduction seemed to disappear in high CHIR conditions. This suggests that 
CHIR or Vitamin C may also affect the degree of siRNA metabolism (Abe, Goda et al. 2009, Chris-
tensen, Litherland et al. 2013, Christensen, Litherland et al. 2014); this might alter the mRNA 
knockdown efficiency, which varies between different experiments (Zhang, Guller et al. 2007, 
Davidson and McCray 2011). 
 It has been known that Vitamin C induces pluripotency acting through TET1 and TET2 
(Blaschke, Ebata et al. 2013, Chen, Guo et al. 2013, Yin, Mao et al. 2013, Gustafson, Yang et al. 
2015). However, our data in Figure 6.2 demonstrated that treatment of Vitamin C increased 
pluripotent cells 1.8-2.0 fold upon knockdown of Tet1 and Tet2; this ratio of Vc rescue was equiva-
lent to that of control siRNAs (1.87 fold). However the effect of knockdown is limited by the residual 
activity of Tet1 and Tet2, or compensation by other TET family members (Wu and Zhang 2011). 
Interestingly, according to the qRT-PCR analysis for Tet genes, Tet2 expression was endogenously 
reduced upon all CH+ treatments. This may indicate that β catenin-induced differentiation silences 
Tet2 gene. Recently, it was demonstrated that Tet2 supports naïve pluripotency, and it can be re-
pressed transcriptionally and post-transcriptionally for primed pluripotency, in contrast Tet1 facili-
tates primed pluripotent states (Fidalgo, Huang et al. 2016). Based on this result, Tet2 may critical-
ly function in promoting ESC self-renewal and decreasing differentiation. It would be interesting to 
determine if TET2 over-expression could resist CH-induced differentiation. In addition, although the 
TET2 transcript is reduced, we should also determine that TET2 protein is similarly reduced. The 
semi-quantitative technique, Western blotting could be used to test the Tet2 expression at the pro-
tein levels (Taylor and Posch 2014). 
 Another published paper also argued that, induction of pluripotency is markedly improved 
by Vitamin C-dependent enzymes, such as KDM2A and KDM2B (Wang, Chen et al. 2011). Inter-
estingly, transfection with either Kdm2 siRNA reduced the level of Rex-EGFP in high CHIR, sug-
gesting that Kdm2 is a negative regulator of differentiation. However, this increase in differentiation  
is corrected by addition of Vc, indicating that Kdm2 does not mediate Vc effect (Figure 6.3B). A re-
cent paper by Lu et al. (2015) discovered that in the nucleus, non-phosphorylated β catenin is 
methylated by Kdm2, thereby leading to its ubiquitination and degradation (Fagotto 2015, Lu, Gao 
et al. 2015). Based on their demonstrations, it is easy to speculate that Kdm2 knockdown can sta-
bilise and promote β catenin activity, and may upregulate differentiation markers in Figure 6.6 
(Chen, Blair et al. 2013, Lu, Gao et al. 2015). This may explain why those ESCs in high CHIR 
treated with Kdm2a and Kdm2b siRNAs are more differentiated. In summary, the key interesting 
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findings here are that Kdm2 modulates β catenin signaling, such that its knockdown enhances β 
catenin-induced differentiation, and despite this enhanced differentiation, Vc retains the capacity to 
rescue self-renewal. 
 In addition, using qRT-PCR analysis for Kdm2 mRNAs, we found that Kdm2b expression 
levels were noticeably increased in all high CHIR conditions by at least 50%. This may suggest 
that Kdm2b is upregulated under high β catenin activity. Recently, KDM2B enzymes were reported 
to suppress WNT signalling by transcriptionally regulating several ligands (Andricovich, Kai et al. 
2016). In addition, downregulation of Kdm2b in Xenopus, zebrafish, and mice led to embryonic 
lethality (Huang, Kathrein et al. 2013, Lu, Gao et al. 2015, Andricovich, Kai et al. 2016), highlighting 
the significance of Kdm2b in cell development. Hence, we surmise that, in response to excessive β 
catenin activity caused by high CHIR treatment, KDM2B may increase to prevent the abnormal 
level of β catenin activity in ESCs as a negative feedback; this may help rescue developing cells 
from the embryonic lethality. It would be interesting to determine if over-expressing Kdm2b during 
high CH cultures would prevent differentiation by modulating β catenin activity. 
 In addition to Tet and Kdm proteins, there are many potential enzyme targets of Vitamin C. 
This is because Vitamin C functions as an electron donor in any iron-dependent proteins (Monfort 
and Wutz 2013). Therefore, it may not be a single target that drives most of the Vc-dependent ac-
tivities. Rather than the single factor, a range of Vc targets may likely form a global network and 
associate with other factors, presenting their effects on growth (Figure 4.3) and differentiation (Fig-







Figure 6.6. Diagram of potential β 
catenin control by KDM2. GSK3β activity 
is blocked by its inhibitor, CHIR leading to 
loss of phosphorylation and stabilization of β 
catenin. KDM2 enzymes de-methylate non-
phosphorylated β catenin inducing its degra-
dation to prevent ESC differentiation (Chen 
et al. 2013; Meek et al. 2013; Lu et al. 2015). 
Abbreviations: CHIR, CHIR99021. (Created 
using information from different sources).
 
7. Conclusions and Future Perspectives
 Rat ESCs can be used to produce complex genetic models (Buehr, Meek et al. 2008, 
Meek, Buehr et al. 2010).  They are derived from the blastocyst-stage embryo using the culture 
medium containing 2i plus LIF that promote self-renewal and prevent differentiation (Buehr et al., 
2008; Li et al., 2008). However, the long term culture of rESC in 2i + LIF medium displays higher 
expression levels of differentiation genes (Meek, Wei et al. 2013). Esteban et al. (2010) demon-
strated that Vitamin C improves the growth and formation of mouse induced pluripotent stem (iPS) 
cell colonies. The importance of Vitamin C in somatic cell reprogramming protocols suggested that 
this agent could also play a role in regulating the pluripotency of rESCs (Esteban, Wang et al. 
2010, Shi, Zhao et al. 2010, Esteban and Pei 2012). Vitamin C is known as an antioxidant and re-
tains the activity of iron-mediated demethylases that can change the epigenetic profile of cells 
(Monfort and Wutz 2013). In spite of these dioxygenases being involved in a variety of cell sig-
nalling pathways, Vitamin C is seldom used in standard ESC culture media. Here we have demon-
strated the benefits of epigenetic modulator Vitamin C in rESC self-renewal and pluripotency. 
 Our data indicated that Vitamin C improves growth of rat ESCs. In addition, Vitamin C pre-
vents ESCs from β catenin-induced differentiation, by upregulating pluripotency genes (e.g. Esrrb 
and Nanog) and downregulating differentiation genes (e.g. Gata4 and Brachyury). Although these 
Vitamin C effects were measured by different approaches, both two influences on growth and ESC 
differentiation may originate and be potentially regulated from the same Vitamin C downstream 
targets. It is possible that cell division cycle can affect ESC differentiation (Li, Ballabeni et al. 2012, 
Li and Kirschner 2014). ESCs are characterised by a rapid cell cycle structure with shortened G1 
and G2 phases, and a high proportion of cells in S phase (White and Dalton 2005, Orford and 
Scadden 2008, Hindley and Philpott 2013, Kapinas, Grandy et al. 2013). If the G1 phase of cell 
cycle is truncated, and cells are driven to grow more rapidly, ESC differentiation can be sup-
pressed (Li, Ballabeni et al. 2012, Li and Kirschner 2014, Re, Workman et al. 2014). Conversely, if 
G1 phase is lengthened, early multi-lineage differentiation is induced in ESCs (Calder, Roth-Albin 
et al. 2013). The interaction between ESC differentiation and cell cycle can be assessed by the co-
regulated genes. These overlapping genes are primarily observed to be the genes responsible for 
cell cycle regulation, specifically, replication factors (e.g. PCNA, MCM6, CKS1B, CKS2, and 
CDC6) and cyclins (e.g. CCNB1, CCNA2 and CCNE2) as well as mitotic spindle assembly factors 
(e.g. CDC20 and TACC3) (Re, Workman et al. 2014). In addition, there are also other factors that 
perform dual roles in differentiation and cell proliferation, such as H1 linker histone, known to regu-
late mitotic chromosome and Hox gene (Maresca, Freedman et al. 2005, Zhang, Liu et al. 2012) 
and DNA replication inhibitor (Geminin), known to regulate transition between pluripotency and lin-
eage commitment (Lim, Hummert et al. 2011, Re, Workman et al. 2014). More importantly, previ-
ous studies argued that the abbreviated cell cycle is functionally connected to pluripotency (Singh 
and Dalton 2009, Ghule, Medina et al. 2011). In particular, Nanog, Oct4 and Myc are positively cor-
related with cell cycle factors, such as CDKs and cohesin factors (e.g. RAD21) (Singh and Dalton 
2009, Nitzsche, Paszkowski-Rogacz et al. 2011). In summary, the interaction between early lin-
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eage-commitment and cell cycle regulation indicates that Vitamin C effects on growth and differen-
tiation may originate from the identical targets. Therefore, in the future experiments, we should also 
analyse cell cycle changes in the presence of Vitamin C. This will give more specific ideas how 
rESCs are regulated by Vc and may highlight the potential downstream targets. 
 We discovered that Vitamin C does not block MEK-driven differentiation (Figure 4.6), but it 
does prevent β catenin-dependent differentiation (Figure 4.9). Based on the result that D-isoascor-
bic acid, the Vitamin C isomer, lacking cofactor activity has little effect on β catenin-induced differ-
entiation (Figure 4.11), we can conclude that the Vitamin C effect primarily results from cofactor 
activity. In our experiments, specific Tet and Kdm genes were knocked individually. However, 
knockdown of each target independently can be very weak, because there are other Tet and Kdm 
subtype members (Klose, Kallin et al. 2006, Tan and Shi 2012, Kohli and Zhang 2013, Dimitrova, 
Turberfield et al. 2015). Tet1 catalyses oxidation of the 5-position of cytosine (5-methylcytosine, 
5mC) at transcription start sites and gene promoters, while Tet2 catalyses oxidation of 5mC in exon 
boundaries and gene bodies of actively-expressed exons and genes, respectively (Huang, Chavez 
et al. 2014). Despite the dissimilarity between them, it can be possible that Tet1 and Tet2 compen-
sate for each other, due to their overlapping functions in catalysing oxidation of 5mC for the re-
moval of DNA methylation (Tan and Shi 2012, Kohli and Zhang 2013, Hill, Amouroux et al. 2014). 
According to this overlap, silencing a single gene may produce no dramatic phenotype changes, 
unless one enzyme is vital in their cell signalling pathways. Hence it would be noteworthy to 
knockdown both associated members, for example, Tet1 and Tet2 together or Kdm2a and Kdm2b. 
 As an alternative to the use of siRNAs, there is another option of employing short hairpin 
RNA (shRNA) technique (Paddison, Caudy et al. 2002). shRNA is a double stranded RNA (dsRNA) 
containing a hairpin loop, which can silence genes through the RNAi system (Brummelkamp, 
Bernards et al. 2002, Paddison, Caudy et al. 2002). siRNA can occur in the cytoplasm or can be 
externally made and introduced into the cell, whereas shRNA is synthesised from a DNA construct 
delivered to the nucleus of the target cell via viral vectors (gene expression cassettes) (Rao, 
Vorhies et al. 2009). The DNA construct encodes a sequence of single stranded RNA (ssRNA) 
molecule and its complement, divided by a certain fragment that allows the ssRNA to fold back on 
itself, producing a dsRNA with a hairpin turn (Rao, Vorhies et al. 2009). The delivered DNA can be-
come part of the target cell’s own genome and make this host cell to synthesise the shRNA mol-
ecule, which is subsequently processed by the endoribonuclease Dicer into siRNA and proceeds 
along the pathway of RNAi via RNA-induced silencing complex (RISC) to silence targets (Rao, 
Vorhies et al. 2009). Since shRNA assimilates into endogenous microRNA pathways, it is markedly 
more efficient than siRNA (Siolas, Lerner et al. 2005, McAnuff, Rettig et al. 2007, Vlassov, Korba et 
al. 2007) and shows low degradation of exogenously introduced shRNA. Specifically, just 1% of the 
introduced siRNA remains in the target cells 48 hours after transfection, whereas shRNA are con-
tinuously generated by the host cell’s own machinery, highlighting that its effect is more durable 
(Rao, Vorhies et al. 2009). In addition, siRNA concentrations required for efficient knockdown are 
relatively high (that is, in the nano-mole range), whereas just 5 copies of shRNA incorporated in 
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host DNA is sufficient to give continual knockdown effect; this low dosage indicates that shRNA is 
less likely to exhibit ‘off-target’ effects than siRNA (Rao, Vorhies et al. 2009). Also, shRNA shows 
lower toxicity, immune activation and inflammation (Rao, Vorhies et al. 2009). On the other hand, 
the limitation is the use of an expression vector that may have safety issues (Wang, Rao et al. 
2011). 
 Since RNAi-based systems including siRNA and shRNA are comprised of RNA molecules, 
it is inherently fragile and naturally difficult to enter the cytoplasm; once there, it is rapidly degraded 
(Rao, Vorhies et al. 2009). Due to this, relatively high concentrations are usually employed for effi-
cient gene silencing, and also the administration periodically needs to be repeated. In short, they 
are transient, short lived and only a small percentage of cells are transfected. Therefore, CRISPR-
Cas9 gene editing is required to accurately assess prime candidates of Vitamin C for the study of 
their roles (Jinek et al. 2012). This CRISPR-Cas technology stems from a microbial adaptive im-
mune system, as it can be used to protect bacteria and archaea against invading viruses by de-
grading their viral genomes (Ran, Hsu et al. 2013, Barrangou, Birmingham et al. 2015). With the 
aid of guide RNA (gRNA) containing a 20-nt targeting sequence, Cas9 nucleases can cleave the 
target gene flanked by the PAM sequence in Figure 6.7 (Brouns, Jore et al. 2008, Garneau, Dupuis 
et al. 2010, Deltcheva, Chylinski et al. 2011, Jinek, Chylinski et al. 2012, Ran, Hsu et al. 2013). 
This CRISPR-Cas approach is highly specific and efficient, and also relatively easy to design for 
genome editing for a range of cell lines (Ran, Hsu et al. 2013). CRISPR-mediated gene knockout 
can be conducted by designing and constructing CRISPR plasmids to chosen targets, and trans-
fecting into ESCs. Additionally, the degree of site-specific mutation should be measured to validate 
and determine the efficiency of CRISPR activity. Transfecting validated CRISPR into ESC will 
knock-out targets only if the NHEJ generates a mutation that creates a frameshift, or the HDR is 
employed to make specific changes (Ran, Hsu et al. 2013, Doudna and Charpentier 2014, Barran-
gou, Birmingham et al. 2015). Subsequently, comparing control and knock-out cell lines in the 
presence or absence of Vitamin C will identify exact role of Vitamin C-mediated downstream tar-
gets. 
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Figure 6.7. The CRISPR-
Cas9 complex. Guide RNAs 
deliver Cas9 to the target DNA 
sequence followed by the PAM 
sequence. Cas9 then intro-
duces a double strand break 
in the target DNA (Jinek, et al. 
2012, Cong, et al. 2013, Jinek, 
et al. 2013, Mali, et al. 2013) 
(Image adapted from Nash 






 The CRISPR-Cas9 system can also be used to modulate expression of a gene of interest 
transcriptionally, not just at the level of genomic DNA (Barrangou, Birmingham et al. 2015). The 
CRISPR-associated protein Cas9 was identified to contain two nuclease domains HNH and RuvC-
like in Figure 6.7 (Bolotin, Quinquis et al. 2005, Haft, Selengut et al. 2005, Makarova, Grishin et al. 
2006). HNH domain is used to break the DNA strand which corresponds to the 20 nucleotide guide 
sequence of CRISPR RNA (crRNA), whereas RuvC-like domain breaks the DNA strand opposite 
the corresponding strand (Gasiunas, Barrangou et al. 2012, Jinek, Chylinski et al. 2012). Hence, 
mutating both HNH and RuvC-like domains can make a Cas9 endonuclease to act as an RNA-
guided DNA binding factor (Gasiunas, Barrangou et al. 2012, Jinek, Chylinski et al. 2012). When 
fused to repressor or activator domains, this catalytically deactivated Cas9 (termed dCas9) can 
direct transcriptional suppression or activation of a target gene employing sgRNA (single guide 
RNA) directed against promoter sites; these techniques are called CRISPRi and CRISPRa (Cheng, 
Wang et al. 2013, Gilbert, Larson et al. 2013, Larson, Gilbert et al. 2013, Qi, Larson et al. 2013, 
Gilbert, Horlbeck et al. 2014, Konermann, Brigham et al. 2015) (advances 133-134). In terms of the 
CRISPRi technique, it can repress RNA polymerase binding, transcription factor binding or tran-
scriptional elongation, according to the regions recognised by the complex of dCas9-guide RNA 
(Qi, Larson et al. 2013, Doudna and Charpentier 2014). Hence it contains analogous advantages 
to RNAi system, such as partial suppression, reversibility and transience (Guo, Barry et al. 2014, 
Barrangou, Birmingham et al. 2015). In addition to these similar advantages, this CRISPRi strategy 
was demonstrated to show no observable off-target effects (Qi, Larson et al. 2013), and to sup-
press multiple genes of interest simultaneously, and also its effects show reversible (Bikard, Jiang 
et al. 2013, Gilbert, Larson et al. 2013, Qi, Larson et al. 2013, Zhao, Dai et al. 2014).  
 According to our independent siRNA knockdown for each target (Figure 6.2A and 6.3A), we 
have not observed any significant phenotype differences with Tet1/2 or Kdm2a/2b siRNAs, com-
pared to control siRNAs. However, using libraries of CRISPR vectors, we may identify phenotypes 
of cells having mutations in multiple Vitamin C-associated genes (Shalem, Sanjana et al. 2015). In 
previous experiments, genetic screens depended largely upon shRNA-based screens that involve 
extensive off-target effects and incomplete knockdown (Root, Hacohen et al. 2006, Shalem, San-
jana et al. 2015). By contrast, CRISPR technology can generate highly specific, genomic alteration 
in genes of interest (Barrangou, Birmingham et al. 2015). In addition, target gene recognition by a 
Cas9 nuclease requires only a small 20 nucleotide-homology between the target gene locus and 
the gRNA (Wu, Kriz et al. 2014, Tsai and Joung 2016). This aspect makes the CRISPR-Cas9 tech-
nology easy, fast and cost-effective for large scale functional genomic studies (Zhou, Zhu et al. 
2014, Vidigal and Ventura 2015). CRISPR pooled libraries are composed of thousands of unique 
plasmid vectors, each expressing a gRNA designed to a different gene of interest (Shalem, San-
jana et al. 2014, Wang, Wei et al. 2014, Zhou, Zhu et al. 2014). In a genetic CRISPR screening 
experiment, the pooled library is administered to desired cells to produce a large population of mu-
tant cells, which are then screened for a desired phenotype of interest (Shalem, Sanjana et al. 
2015). Overall, CRISPR-based approach can be a powerful future approach for the identification of 
Vitamin C targets. 
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 Our luciferase data demonstrated that β catenin activity is not directly regulated by Vitamin 
C (Figure 4.12), suggesting that it acts via an alternative pathway. In addition, our siRNA knock-
down data indicated that Tet1 and Tet2 might not be actively involved in the Vitamin C-mediated 
activity, whereas Kdm2a and Kdm2b might be involved in regulating β catenin-induced differentia-
tion. However the effect of knockdown is limited by the residual activity of Tet and Kdm. If those 
TET and KDM demethylases are accessed by the CRISPR-Cas9 afterward and it confirmed that 
they do not mediate Vitamin C activity, other Vitamin C-downstream candidates need to be 
screened. 
 Recently, histone 3 lysine 9 (H3K9) methylation has attracted some attention, because it 
acts as a potent roadblock in the process of induced pluripotency (Soufi, Donahue et al. 2012, 
Chen, Liu et al. 2013). Among histone demethylases that can be affected by cofactor activity of vit-
amin C, Kdm3a enzymes involved in spermatogenesis seem to have important roles in H3K9 
methylation (Okada, Scott et al. 2007, Shi, Zhao et al. 2010). It has also been demonstrated that 
BIX01294, an inhibitor agent of G9a (H3K9 methyltransferase), can promote somatic cell repro-
gramming to induced pluripotent stem cells (iPSCs), suggesting the significance of H3K9 meth-
ylation (Feng, Ng et al. 2009, Shi, Zhao et al. 2010). Hence, it is tempting to knockdown the KDM3 
families that inhibit formation of H3K9me1/me2 (Yamane, Toumazou et al. 2006, Kim, Kim et al. 
2010, Kim, Kim et al. 2012) as well as KDM4 families which de-methylate H3K9me3 to see if Vita-
min C effects rely on these demethylases (Cloos, Christensen et al. 2006, Fodor, Kubicek et al. 
2006, Klose, Yamane et al. 2006, Whetstine, Nottke et al. 2006). 
 According to our results (Figure 6.3), KDM2 demethylases may be involved in maintaining 
ESC identity. That is, KDM2a and KDM2b may possibly retain a pluripotent state of rESCs, as their 
knockdown noticeably reduced the population of Rex1-GFP positive cells. It has been known that 
KDM2 families de-methylate the methylated lysine 36 on histone H3. According to this H3K36, oth-
er proteins such as Kdm4a, Kdm4c and Kdm8 are also involved in removing these lysine methyla-
tions on histone H3. Specifically, Kdm4a and Kdm4c target H3K36me3 (Cloos, Christensen et al. 
2006, Klose, Yamane et al. 2006), whereas Kdm8 prevents formation of H3K36me2 (Hsia, Tepper 
et al. 2010). Therefore, it would be interesting to knockdown those demethylases to see if they are 
involved in promoting rESC self-renewal. 
 Most recently, it was demonstrated that Vitamin C enhances pluripotency of human iPSCs, 
acting through the histone demethylase KDM5A (JARID1A) (Eid and Abdel-Rehim 2016). This en-
zyme removes lysine methylation of H3K4me2/me3 (Klose, Yan et al. 2007, Eid and Abdel-Rehim 
2016), which is known to be involved in haematopoietic abnormalities (Klose, Yan et al. 2007). 
Hence, it is also worthwhile to investigate whether this factor mediates the effects of Vitamin C in 
rESCs. 
 Inspired by the importance of Vitamin C in somatic cell reprogramming protocols, we tested 
whether this agent could also play a role in regulating the pluripotency of rESCs (Esteban, Wang et 
al. 2010, Shi, Zhao et al. 2010, Esteban and Pei 2012). Vitamin C is known to have antioxidant 
properties and retains the activity of iron-mediated DNA and histone demethylases (Monfort and 
Wutz 2013). In spite of these dioxygenases being involved in hypo-methylation that characterises 
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ESCs (Leitch, McEwen et al. 2013), Vitamin C is rarely administered to standard ESC culture me-
dia. This may be because the fact that rodents can generate vitamin C might have neglected it in 
the standard media or experiments to prove a beneficial Vitamin C influence in media have often 
not been convinced (Monfort and Wutz 2013). Here, we have demonstrated the benefits of epige-
netic modulator Vitamin C in rESC self-renewal and pluripotency. As this enzymatic function is criti-
cal in enhancing a self-renewing, pluripotent state of ESCs, Vitamin C can be employed as a sup-
plement to copy physiological activity levels. Our demonstrations and future experiments may sug-
gest to overcome the limitations of the long-term culture of rESC in standard 2i + LIF media. Con-
sequently, this will help generate better culture systems, and will then contribute to reliable mainte-
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Table S1. Primer pairs of different markers for qRT-PCR. GAPDH was employed as a house-
keeping gene (normaliser), relative to which the expression level is defined. Esrrb and Nanog are 
ESC markers. Gata4 and Brachyury are differentiation markers. Axin2 is a target of β catenin. 
Tet1, Tet2, Kdm2a and Kdm2b are markers of the potential Vitamin C targets.


































− PD    2i + LIF
+ Vc 
− PD
Figure S1. Vitamin C does not rescue ESCs from MEK-induced differentiation. In the A and 
B, ESCs (135-3 cell line) were cultured in media containing 2i + LIF or 2i with 3 µM CHIR (-PD) or 3 µM 
CHIR + 100 µM Vitamin C (-PD + Vc) for 4 days. Panel A shows bright-field and fluorescence images of the 
same cells (magnification X10). In panel B, the same rESC cultures were analysed (1x104 cells) by flow 
cytometry at day 4. Abbreviations: CHIR, CHIR99021; PD, PD0325901; LIF, leukaemia inhibitory factor; Vc, 
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− PD
Figure S2. Vitamin C does not prevent ESCs from MEK-dependent differentiation. In the A 
and B, ESCs (141-5 cell line) were cultured in media containing 2i + LIF or 2i with 3 µM CHIR (-PD) or 3 
µM CHIR + 100 µM Vitamin C (-PD + Vc) for 4 days. Panel A shows bright-field and fluorescence images of 
the same cells (magnification X10). In panel B, the same rESC cultures were analysed (1x104 cells) by flow 
cytometry at day 4. Abbreviations: CHIR, CHIR99021; PD, PD0325901; LIF, leukaemia inhibitory factor; Vc, 




+ CH    2i + LIF
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Figure S3. Vitamin C rescues ESCs from β catenin-induced differentiation. (A): rESCs (135-3 cell 
line) were cultured in media containing 2i + LIF or 2i with 4 µM CHIR (+CH) or 4 µM CHIR + 100 µM Vitamin C 
(+ CH + Vc) for 5 days. The panels shows bright-field (upper) and fluorescence images (lower) of the same 






















































































Figure S4. Vitamin C upregulates Esrrb and Nanog, and downregulates Gata4. Quantitative 
reverse transcriptase polymerase chain reaction (qRT-PCR) analysis for Esrrb, Nanog and GATA4 genes. 
The graphs indicate the level of gene expressions in ESCs (135-3 line). These ESCs were cultured in 
medium containing 2i + LIF (red) or 2i with 5 µM CHIR (+CH, blue) or 5 µM CHIR + 100 µM Vitamin C 
(+CH +Vc, green) for 5 days. Abbreviations: CHIR (CH), CHIR99021; LIF, leukaemia inhibitory factor; Vc, 
Vitamin C.
Esrrb
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Figure S5. Vitamin C does not markedly affect the Axin2 expression level. qRT-PCR analysis for Ax-
in2 gene. The graphs indicate the level of Axin2 expression in ESCs (135-4 and 135-6 cell lines). These 
ESCs were cultured in media containing 2i + LIF (red) or 2i with 5 µM CHIR (+CH, blue) or 5 µM CHIR + 
100 µM Vitamin C (+CH +Vc, green) for 5 days. Abbreviations: CHIR, CHIR99021; LIF, leukaemia inhibitory 




Figure S6. Lef1 siRNA can prevent ESCs from CHIR-induced differentiation. (A): Bright-field 
(upper) and fluorescence (lower) images (magnification X10) of rESCs (135-4) cultured in media containing 
2i + LIF, 6 µM CHIR + 50 nM negative siRNA (-ve siRNA + CH) and 6 µM CHIR + 50 nM Lef1 siRNA (Lef1 
siRNA + CH) for 5 days. (B): The same cells were then analysed (1x104 cells) by flow cytometry at day 5. 
















































































Figure S7. Titration of siRNA concentration for efficient knockdown. qRT-PCR analysis for 
Tet1, Tet2, Kdm2a and Kdm2b mRNAs. The graphs indicate the level of gene expressions in rESCs (135-4 
cell line) transfected with the appropriate siRNAs at 25, 50, 100 and 200 nM for 24 hours and concurrently 
cultured in media containing 2i + LIF for 3 days. Abbreviation: negative siRNA, Control siRNA.
Negative 
siRNA
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